Securities and Exchange Commission
Washington, DC 20549
FORM 10-QSB
(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended July 31, 1996
[ ] TRANSITION REPORT PURSUANT TO 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from _______________ to ______________
Commission file number 0-20256
KURZWEIL APPLIED INTELLIGENCE, INC.
- --------------------------------------------------------------------------------
(Exact name of small business issuer as specified in its charter)
Delaware 04-2815079
- -------------------------------- -------------------------------------
(State or other jurisdiction of (IRS Employer Identification Number)
incorporation or organization)
411 Waverley Oaks Road, Waltham, Massachusetts 02154
- --------------------------------------------------------------------------------
(Address of principal executive offices)
(617) 893-5151
- --------------------------------------------------------------------------------
(Issuer's telephone number)
- --------------------------------------------------------------------------------
(Former name, former address and former fiscal year, if changed since
last report)
Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.
Yes [ X ] No [ ]
On July 31, 1996, there were 9,056,916 shares of Common Stock outstanding.
Transitional Small Business Disclosure Format (Check one): Yes [] No [X]
1
<PAGE>
KURZWEIL APPLIED INTELLIGENCE, INC.
FORM 10-QSB
INDEX
<TABLE>
<CAPTION>
Page
----
<S> <C> <C>
Part I - Financial Information
Item 1. Financial Statements
Balance Sheets as of July 31, 1996 and January 31, 1996 3
Statements of Operations for the Three and Six Month Periods
Ended July 31, 1996 and 1995 4
Statements of Cash Flows for the Three and Six Month Periods
Ended July 31, 1996 and 1995 5
Notes to Financial Statements 6
Item 2. Management's Discussion and Analysis of Financial Condition
and Results of Operations 8
Part II - Other Information
Item 1. Legal Proceedings 13
Item 4. Submission of Matters to a Vote of Security Holders 13
Item 6. Exhibits and Reports on Form 8-K 13
Signatures 14
Exhibit Index 15
</TABLE>
2
<PAGE>
PART I - FINANCIAL INFORMATION
KURZWEIL APPLIED INTELLIGENCE, INC.
BALANCE SHEETS
Unaudited
(in thousands)
Item 1. Financial Statements
<TABLE>
July 31, January 31,
1996 1996
-------------- ------------
<S> <C> <C>
ASSETS
Current assets:
Cash and cash equivalents $3,179 $2,084
Marketable securities available for sale 501
Trade accounts receivable, less allowances of $258,000 and
$287,000 at July 31, 1996 and January 31, 1996,
respectively 2,124 1,221
Inventory 473 398
Other current assets 343 262
-------------- ------------
Total current assets 6,119 4,466
Property and equipment, net 821 924
Intangible assets 1,192 1,745
Capitalized software development costs, net 2,252 1,593
Other assets 115 136
-------------- ------------
Total assets $10,499 $8,864
============== ============
LIABILITIES
Current liabilities:
Accounts payable $1,151 $665
Accrued expenses 2,266 2,211
Capital lease obligations 17 29
Current portion of other long-term liabilities 1,019 902
-------------- ------------
Total current liabilities 4,453 3,807
Other long-term liabilities 1,152 2,169
Commitments and contingencies
STOCKHOLDERS' EQUITY
Preferred stock, $.01 par value, 1,000,000 shares
authorized; none issued and outstanding
Common stock, $.01 par value; 15,000,000 and 10,000,000 shares
authorized at July 31, 1996 and January 31, 1996,
respectively; 9,056,916 and 5,733,387 shares issued and
outstanding at July 31, 1996 and January 31, 1996,
respectively 91 57
Additional paid-in capital 66,726 57,647
Common stock to be issued 5,075
Accumulated deficit (61,923) (59,891)
-------------- ------------
Total stockholders' equity 4,894 2,888
-------------- ------------
Total liabilities and stockholders' equity $10,499 $8,864
============== ============
</TABLE>
The accompanying notes are an integral part of the financial statements.
3
<PAGE>
KURZWEIL APPLIED INTELLIGENCE, INC.
STATEMENTS OF OPERATIONS
Unaudited
(in thousands, except for per share amounts)
<TABLE>
<CAPTION>
Three Months Ended Six Months Ended
July 31, July 31,
--------------------------- -------------------------
1996 1995 1996 1995
------------ --------- ---------- ---------
<S> <C> <C> <C> <C>
Revenues:
Product and license revenue $1,735 $2,101 $2,973 $4,427
Maintenance revenue 462 415 934 797
------------ --------- ---------- ---------
Total revenues 2,197 2,516 3,907 5,224
------------ --------- ---------- ---------
Operating costs and expenses:
Cost of product, license and
maintenance revenue 860 961 1,741 2,256
Sales and marketing 989 873 1,939 1,803
Research and development 753 638 1,431 1,116
General and administrative 364 404 896 740
------------ --------- ---------- ---------
Total operating costs and expenses 2,966 2,876 6,007 5,915
------------ --------- ---------- ---------
Operating loss (769) (360) (2,100) (691)
Interest expense 1 4 2 6
Interest income 27 53 58 112
Other (expense) income, net 5 13 12 50
============ ========= ========== =========
Net loss ($738) ($298) ($2,032) ($535)
============ ========= ========== =========
Net loss per common share ($0.09) ($0.04) ($0.27) ($0.08)
============ ========= ========== =========
Weighted average number of common
shares outstanding 8,440,978 6,757,632 7,616,860 6,744,916
============ ========= ========== =========
</TABLE>
The accompanying notes are an integral part of the financial statements.
4
<PAGE>
KURZWEIL APPLIED INTELLIGENCE, INC.
STATEMENTS OF CASH FLOWS
Unaudited
(in thousands)
<TABLE>
<CAPTION>
Six Months Ended July 31,
-----------------------------------
1996 1995
----------- -----------
<S> <C> <C>
Cash flows from operating activities:
Net loss ($2,032) ($535)
Adjustments to reconcile net loss to net cash
( used ) by operating activities:
Depreciation 260 256
Amortization 904 953
Provision on doubtful accounts 5
Change in operating assets and liabilities:
(Increase) in accounts receivable (903) (94)
(Increase) decrease in inventory (75) 320
(Increase) in other assets (68) (106)
Increase (decrease) in accounts payable 486 (56)
Increase (decrease) in accrued expenses
and other liabilities 55 (858)
---------- -----------
Net cash (used) by operating activities (1,373) (115)
---------- -----------
Cash flows from investing activities:
Sale of marketable securities available for sale 501
Payments for property and equipment, net (157) (326)
Capitalized software development costs (1,000) (611)
---------- -----------
Net cash (used) in investing activities (656) (937)
---------- -----------
Cash flows from financing activities:
Payments on capital lease obligations (12) (47)
Payments on licensing agreement (902) (798)
Proceeds from issuance of capital stock, net 4,038 56
---------- -----------
Net cash provided by (used) in financial activities 3,124 (789)
---------- -----------
Net increase (decrease) in cash 1,095 (1,841)
Cash and cash equivalents, beginning of period 2,084 4,307
---------- -----------
Cash and cash equivalents, end of period $3,179 $2,466
========== ===========
</TABLE>
The accompaying notes are an integral part of the financial statements
5
<PAGE>
KURZWEIL APPLIED INTELLIGENCE
NOTES TO FINANCIAL STATEMENTS
1. BASIS OF PRESENTATION
---------------------
For purposes of this Form 10-QSB, all references to "Fiscal 1997" mean the
fiscal year of Kurzweil Applied Intelligence, Inc. (the "Company") ending
January 31, 1997. All references to "Fiscal 1996" mean the Company's fiscal year
ended January 31, 1996.
The accompanying financial statements of the Company have been prepared in
accordance with generally accepted accounting principles for interim financial
information and with the instructions to Form 10-QSB and Item 310 of Regulation
S-B. Accordingly, they do not include all of the information and footnotes
required by generally accepted accounting principles for complete financial
statements. In the opinion of management, all adjustments (consisting of normal
recurring accruals) considered necessary for the fair presentation have been
included. The results of operations of any interim period are not necessarily
indicative of the results of operations for the fiscal year. For further
information, refer to the financial statements and footnotes thereto included in
the Company's 1996 Annual Report for the fiscal year ended January 31, 1996.
2. LEGAL PROCEEDINGS
-----------------
Texas Litigation On September 11, 1995, one of the Company's shareholders who
opted out of the shareholder class action litigation, which was subsequently
settled in April of 1995, filed a complaint in Dallas County, Texas against the
Company and certain of its current and former directors and officers. The
complaint asserts that the defendants committed fraud and violated Texas state
law and unnamed federal securities laws. The shareholder seeks $1,500,000 in
damages as a result of his purchase of 1,000 shares of the Company's Common
Stock. Management believes that the damages being claimed are excessive and
intends to defend its position vigorously. Management does not believe there is
a reasonable possibility of a material adverse outcome that will exceed amounts
already reserved. If any additional loss occurs, management believes that the
loss will not have a material adverse impact on the Company's financial position
or results of operations.
Nasdaq Regulatory Requirements
- ------------------------------
At April 30, 1996 the Company was not in compliance with NASD net worth
requirements for the continued listing of the Company's Common Stock on the
Nasdaq National Market. The Company received from Nasdaq an extension of time
until August 19, 1996 to demonstrate compliance with the continued listing
requirements. The Company believes that with the filing of this Form 10-QSB on
August 19, 1996, the Company will be in compliance as of July 31, 1996.
There can be no assurance that the Company will be able to maintain its
listing. Suspension of the Company's common stock from trading on the Nasdaq
National Market may adversely affect the price of the Company's common stock.
6
<PAGE>
3. INTANGIBLE ASSETS AND OTHER LONG-TERM LIABILITIES
-------------------------------------------------
On September 23, 1993, the Company and Dragon Systems, Inc. (Dragon) settled
certain patent infringement litigation between the two companies. As part of
such settlement, the Company licensed certain Dragon patents related to
continuous speech and other aspects of speech recognition technology. The
Company paid Dragon $1,331,250 in fiscal 1994, $798,000 in fiscal 1996 and
$901,810 in June 1996. Under the terms of this agreement, the Company was
committed to make aggregate payments of $5,202,000 including $625,000 in
settlement of amounts due for products sold during periods prior to September
23, 1993. The following mandatory payments remain outstanding as of July 31,
1996:
June 1, 1997 1,019,460
June 1, 1998 1,151,523
--------------
Total $2,170,983
==============
The Company expensed $1,107,600 during fiscal year 1996, and will amortize the
remaining asset of $923,000 on a straight-line basis through May 31, 1997. The
Company expensed $544,000 relating to the Dragon agreement for the six months
ended July 31, 1996. According to the agreement, the Company, if it chooses not
to extend the license, has use of the licensed technology through May 31, 1997.
The final payment will then be made in fiscal 1999.
The Company, at its option, can annually extend the license of the technology
through fiscal 2006, at which time the license would be fully paid. Total
additional annual payments increasing at a rate of 13% per year during the
extension period would approximate $13.5 million
4. Capital Stock
-------------
On May 3, 1996, the Company's Board of Directors adopted an amendment to the
Company's Amended and Restated Certificate of Incorporation to increase the
number of shares of common stock that the Company is authorized to issue from 10
million to 15 million shares. The amendment was approved by stockholders at the
Annual Meeting on July 19, 1996.
On May 10, 1996, the Company received approximately $2,376,000 from the private
sale of 1,320,050 shares of common stock to an investment fund.
On July 31, 1996, the Company received approximately $1,669,500 from the private
sale of 927,500 shares of common stock to accredited investors.
In connection with these private sales, the Company also issued 224,755 warrants
to purchase shares of the Company's common stock at a price of $2.00 per share
which are exercisable for a period of up to ten years.
7
<PAGE>
Item 2. Management's Discussion And Analysis Of Financial Condition And Results
Of Operations
------------------------------------------------------------------------
RESULTS OF OPERATIONS
- ---------------------
Total Revenues. The Company's total revenues consist of revenue from the sale
and licensing of Company products and revenue from maintenance contracts.
Three months. Revenue for the three months ended July 31, 1996 totaled
$2,197,000, 13% lower than the $2,516,000 of revenue in the same period of
the prior year. The decrease in revenue was a result of lower license fees
for the Kurzweil Voice for Windows product for the quarter ended July 31,
1996 of $62,000 as compared to $635,000 for the same period of the prior
year. Included in the revenue for the quarter ended July 31, 1995 was
$600,000 in license fees from one customer of the Kurzweil Voice for
Windows product.
On July 30, 1996, the Company released for shipment the new Kurzweil
Clinical Reporter system, the Company's Windows based medical reporting
product. This release was responsible for the increase in medical product
revenues to $1,066,000 for the second quarter ended July 31, 1996 as
compared to $1,040,000 for the same period of the prior year.
Maintenance revenue for the three month period ended July 31, 1996
increased to $462,000 from $415,000 in the same period of the prior year.
This increase was a result of the larger installed base of medical systems
as compared to the same period of the prior year.
Six Months. Revenue for the six months ended July 31, 1996 totaled
$3,907,000, 25% lower than the $5,224,000 of revenue in the same period of
the prior year. Lower shipments of the Company's VoiceMED products and
lower license fees for the Kurzweil Voice for Windows product was
responsible for the decline in sales for the six month period.
Maintenance revenue for the six month period ended July 31, 1996 increased
to $934,000 from $797,000 in the same period of the prior year. The
increase is a result of the larger installed base of customers as well as
the increased emphasis by the Company on programs to promote receiving
revenue from maintenance contracts.
Cost of Product, License and Maintenance Revenue. Cost of product, license and
maintenance revenue includes hardware costs, manufacturing overhead, system
replacement parts associated with maintenance contracts, third party software
royalties and license fees, and amortization of capitalized software.
8
<PAGE>
Three months. Cost of product, license and maintenance revenue for the
three months ended July 31, 1996 totaled $860,000 or 39% of total
revenues, compared to $961,000 or 38% of total revenues in the same period
of the prior year.
Six Months. Cost of product, license and maintenance revenue for the six
months ended July 31, 1996 totaled $1,741,000 or 44% of total revenues,
compared to $2,256,000 or 43% of total revenues in the same period of the
prior year.
Sales and Marketing Expenses. Sales and marketing expenses include the costs
for marketing, selling and supporting the Company's products.
Three Months. Sales and marketing expenses increased to $989,000 for the
three months ended July 31, 1996 from $873,000 in the same period of the
prior year, representing 45% and 35% of total revenues, respectively. The
increase in expenses was primarily the result of the increased spending to
launch and promote the new Kurzweil Clinical Reporter product line during
the quarter ended July 31, 1996. Those higher expenses included increased
sales force, trade shows, promotion and collateral marketing materials.
Six Months. Sales and marketing expenses increased to $1,939,000 for the
six months ended July 31, 1996 from $1,803,000 in the same period of the
prior year, representing 49% and 35% of total revenues, respectively. The
higher expenses were primarily the result of the increased spending to
launch and promote the new Kurzweil Clinical Reporter product line in the
six months ended July 31, 1996.
Research and Development Expenses. Research and development expenditures consist
principally of personnel costs, allocated facility costs, and associated
equipment amortization and depreciation. A portion of the total research and
development expenditures are capitalized in accordance with Financial Accounting
Standards No. 86, "Accounting for the Costs of Computer Software to be Sold,
Leased or Otherwise Marketed," the amortization of which is included in cost of
product and maintenance revenue.
Three Months. Total research and development expenses, net of
capitalization, for the three month period ended July 31, 1996 increased
to $753,000 or 32% of total revenues, compared to $638,000 or 25% of total
revenues in the same period of the prior year. The increase was primarily
the result of the Company's continued commitment to the development and
enhancement of new products and technology. The research and development
group including technical documentation had 67 people at July 31, 1996 as
compared to 52 at the end of July of the prior year.
9
<PAGE>
Six Months. Total research and development expenses, net of
capitalization, increased to $1,431,000 for the six months ended July 31,
1996 from $1,116,000 in the same period of the prior year, representing
35% and 21% of total revenues, respectively. The increased staffing and
applicable expenses were responsible for the increase in expenses for the
comparable periods.
General and Administrative Expenses. General and administrative expenses include
those costs associated with general corporate needs and administrative
functions.
Three months. General and administrative expenses decreased to $364,000
for the three months ended July 31, 1996 from $404,000 in the same period
of the prior year, representing 15% and 16% of total revenues,
respectively. The decrease was attributable to the Company's continuing
efforts to reduce overhead expenses.
Six months. General and administrative expenses increased to $896,000 for
the six months ended July 31, 1996 from $740,000 in the same period of the
prior year, representing 22% and 14% of total revenues, respectively. The
increase was primarily a result of reserves taken during the first
quarter of fiscal 1997 for litigation expenses.
Income Taxes. At January 31, 1996, the Company had federal net operating loss
carryforwards of approximately $49,000,000. In addition, at January 31, 1996,
the Company had federal tax credit carryforwards of approximately $900,000. The
net operating loss carryforwards expire during the years 1997 through 2009 and
the tax credit carryforwards expire during the years 1997 through 2009.
Substantially all of the Company's net operating loss and tax credit
carryforwards are subject to limitation under the provisions of Section 382 of
the Internal Revenue Code.
LIQUIDITY AND CAPITAL RESOURCES
- -------------------------------
At July 31, 1996, the Company's principal source of liquidity was cash and cash
equivalents of $3,179,000 , as compared to cash and cash equivalents of
$2,084,000 at January 31, 1996.
The Company's operating activities used cash of $1,373,000 for the six months
ended July 31, 1996. The Company will be required to pay $1,019,000 to Dragon
Systems Inc., on June 1, 1997 as part of the patent cross license agreement.
(See Note 3 "Intangible Assets and Other Long - Term Liabilities" of Notes to
Financial Statements.)
At July 31, 1996 the Company had working capital of $1,666,000 as compared to
working capital of $659,000 at January 31, 1996. This increase results
primarily from the private placement equity sales less amounts used to fund
the Company's losses and other commitments.
10
<PAGE>
In order to fund its losses through the transition period of new product
introductions, the Company initiated the process to raise funds through a
private placement of its common stock. On May 10, 1996 the Company received
approximately $2,376,000 from the private sale of 1,320,050 shares of common
stock to an investment fund. On July 31, 1996 the Company received an additional
$1,669,500 through the private sale of 927,500 shares of common stock to
accredited investors. The Company has sufficient funds to sustain its operations
through at least fiscal 1997.
The longer term financial stability of the Company is dependent on achieving
profitable operations and obtaining additional financing. The Company's future
capital requirements will depend on many factors, including the progress and
scope of its research and development programs and the level and profitability
of sales. To the extent that the Company is not able to fund its future
operations through the sale of its products, the Company will need to obtain
additional funds through private or public financing. There is no assurance that
the Company can obtain such additional financing. If the Company requires
additional financing or additional financing is not obtained, the Company will
likely be required to restructure its operations, curtail its spending in
research and development, or attempt a merger or other strategic alliance with
another company. Public financing would be subject to market conditions and
other uncertainties, and no assurance can be given that the Company could obtain
public financing at any time. Either public or private equity financing is
likely to result in dilution of the Company's existing stockholders.
Certain Factors that May Affect Future Results
The Company's future results are subject to substantial risks and uncertainties.
The Company currently derives substantially all of its revenue from the sale of
software licenses that utilize speech recognition to create text documents.
The Company believes that factors affecting the ability of the Company's
products to achieve general market acceptance include product performance,
price, ease of adoption and learning. To be successful in the future the Company
must respond promptly and effectively to the challenges of technological change
and its competitors' innovations by continually enhancing its current products
and developing new products on a timely basis. Certain current and potential
competitors of the Company which are more established, benefit from greater
market recognition and have substantially greater financial, development and
marketing resources than the Company. Competitive pressures or other factors,
including entry into new markets, may result in significant price erosion that
could have a material adverse effect on the Company's result of operations.
The Company believes that its operating results could vary significantly from
quarter to quarter. The Company's license fee revenue in any quarter is
substantially dependent on orders booked and shipped in that quarter. The timing
of license fee revenue is influenced by a number of factors, including; the
timing of individual orders and shipments of its products, customer buying
patterns, changes and delays in product development, and the amount and timing
of sales and marketing expenditures. Because the Company's operating expenses
are based on anticipated revenue levels
11
<PAGE>
and a high percentage of the Company's expenses are relatively fixed in the
short-term, variations in revenue can cause significant fluctuations in
operating results from quarter to quarter and may result in anticipated
quarterly earnings shortfalls or losses. In such event, the market price of the
Company's common stock would likely be materially adversely affected.
Cautionary Statement
From time to time, information provided by the Company or statements made by its
employees may contain "forward-looking" information which involves risk and
uncertainties. In particular, statements contained in Item 2. Management's
Discussion and Analysis of Financial Condition and Results of Operations, which
are not historical facts (including, but not limited to statements concerning
anticipated operating expense levels and such expense levels relative to the
Company's total revenues and expected losses) are "forward-looking statements."
The Company's actual future results may differ significantly from those stated
in any forward-looking statements. Factors that may cause such differences
include, but are not limited to the factors discussed above as well as the
accuracy of the Company's internal estimates of revenue and operating expense
levels. Each of these factors, and others, are discussed from time to time in
the Company's Securities and Exchange Commission filings.
12
<PAGE>
Part II - OTHER INFORMATION
Item 1. Legal Proceedings
-----------------
Reference is made to Footnote 2 of Notes to the Financial Statements for a
description of certain litigation and other legal proceedings.
Item 4. Submission of Matters to a Vote of Security Holders
---------------------------------------------------
On July 19, 1996, the Company held its Annual Meeting of Stockholders. The
matters considered at the meeting consisted of the following.
1. The election of six directors to serve for a term of one year and until
their successors are elected and qualified. The results of the voting were
as follows:
Nominee Votes For Votes Withheld
------------------- --------- --------------
Thomas E. Brew, Jr. 4,610,762 55,275
Steven F. Kaplan 4,610,108 55,929
Raymond C. Kurzweil 4,610,258 64,779
William R. Lonergan 4,587,329 78,708
David R. A. Steadman 4,585,983 80,054
James W. Storey 4,585,683 80,354
2. The approval of an amendment to the Company's Amended and Restated
Certificate of Incorporation to increase the shares of common stock the
Company is authorized to issue from 10 million shares to 15 million shares.
The results of the voting were as follows:
For Against Abstain No Vote
--- ------- ------- -------
4,593,087 66,030 6,920 0
3. The approval of a financing plan to sell shares of common stock of the
Company in a private placement. The results of the voting were as follows:
For Against Abstain No Vote
--- ------- ------- -------
4,591,582 63,987 10,468 0
4. To transact other business including the adjournment of the meeting for
purposes of soliciting additional proxies to achieve a quorum or to obtain
an affirmative vote on other proposals. The results of the voting were as
follows:
For Against Abstain No Vote
--- ------- ------- -------
4,278,017 373,252` 14,768 0
Item 6. Exhibits and Reports on Form 8-K
--------------------------------
6. Exhibits and Reports on Form 8-K
(a) Exhibits.
Exhibit No. Description
---------- ------------
3.1 Restated Certificate of incorporation filed with the
Delaware Secretary of State on July 25, 1996.
10.1 Selling Agency agreement dated July 3, 1996 between the
Company and Miller, Johnson & Kuehn, Incorporated and Form of
Warrant
10.2 Form of Subscription Agreement and Letter of Investment Intent
27 Financial Data Schedule (EDGAR Filing only)
(b) Reports on Form 8-K. During the second fiscal quarter of Fiscal
1997, the following reports on Form 8-K were filed:
Date: May 9, 1996
Item Reported: Item 5 Other Events (Private Placements)
Date: June 28, 1996
Item Reported: Item 4. Changes In Registrant's Certifying
Accountant
No financial statements were filed with the foregoing reports.
13
<PAGE>
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities and
Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
Date: August 19, 1996 KURZWEIL APPLIED INTELLIGENCE, INC.
By: /s/ Thomas E. Brew, Jr.
-------------------------------------
Thomas E. Brew, Jr.
President and Chief Executive Officer
By: /s/ Thomas B. Doherty
-------------------------------------
Thomas B. Doherty
Chief Financial Officer, Vice
President of inance and Treasurer
(principal financial and chief
accounting officer)
14
<PAGE>
EXHIBIT INDEX
Exhibit No. Description At Page
- ---------- ----------- -------
3.1 Restated Certificate of Incorporation filed with the
Delaware Secretary of State on July 25, 1996
10.1 Selling Agency Agreement dated July 3, 1996 between
the Company and Miller, Johnson & Kuehn, Incorporated
and Form of Warrant
10.2 Form of Subscription Agreement and Letter of
Investment Intent
27 Financial Data Schedule (EDGAR Filing only)
15
EXHIBIT 3.1
KURZWEIL APPLIED INTELLIGENCE, INC.
RESTATED CERTIFICATE OF INCORPORATION
The Original Certificate of Incorporation of Kurzweil Applied
Intelligence, Inc. (formerly known as Kurzweil Speech Systems, Inc.)
(the "Corporation") was filed with the Secretary of State on
November 17, 1983. The original Certificate of Incorporation was
amended and restated on May 5, 1992 and further amended on October
28, 1993 and July 22, 1996.
Pursuant to Section 245 of the General Corporation Law, this Restated
Certificate of Incorporation was duly authorized by the Board of Directors of
the Corporation on July 22, 1996. This restatement does not amend the
Corporation's Certificate of Incorporation; it only integrates and restates in a
single document the original Certificate of Incorporation and amendments made
thereto since the original filing date through and including the amendments
approved by stockholders on July 19, 1996, as follows:
FIRST: The name of the corporation is KURZWEIL APPLIED INTELLIGENCE, INC.
(the "Corporation").
SECOND: The address of its registered office in the State of Delaware is 1209
Orange Street, in the City of Wilmington, County of New Castle 19801. The name
of its registered agent at such address is The Corporation Trust Company.
THIRD: The nature of the business or purposes to be conducted or promoted by
the Corporation is as follows:
(a) To engage in the business of designing, developing and producing
computer-based automatic speech recognition products, programs and
devices.
(b) To engage in any lawful act or activity for which corporations may be
organized under the General Corporation Law of the State of Delaware.
FOURTH: The total number of shares of all classes of capital stock which the
Corporation shall have authority to issue is 16,000,000 consisting of --
(a) 15,000,000 shares of Common Stock, par value $0.01, per share; and
(b) 1,000,000 shares of Preferred Stock, par value $0.01, per share.
The holders of Common Stock are entitled to one vote for each share held at all
meetings of stockholders and written actions of stockholders in lieu of a
meeting. There shall be no cumulative voting.
The Board of Directors is authorized, subject to any limitations prescribed by
law, to provide for the issuance from time to time of the shares of Preferred
Stock in one or more series, and by adopting resolutions to establish from time
to time the number of shares to be included in each such series, and to fix the
designation, powers, preferences, and rights of the shares of each such series
and any qualifications, limitations or restrictions thereof. Upon adopting such
resolution or resolutions the Board of Directors shall cause a certificate of
designation setting forth such resolution or resolutions and the number of
shares of stock of such class or series as to which such resolution or
resolutions shall apply to be executed and filed in accordance with applicable
Delaware law. The number of authorized shares of Preferred Stock may be
increased or decreased (but not below the number of shares thereof then
outstanding) by the affirmative vote of the holders of a majority of the Common
Stock, without a vote of the holders of the Preferred Stock, or of any series
thereof, unless a vote of any such holders is required pursuant to the
certificate or certificates establishing the series of Preferred Stock.
Page 1 of 6
<PAGE>
FIFTH: The following provisions are inserted for the management of the business
and the conduct of the affairs of the Corporation; and for defining and
regulating the powers of the Corporation and its directors and stockholders and
are in furtherance and not in limitation of the powers conferred upon the
Corporation by statute:
(a) The election of directors need not be by written ballot.
(b) The Board of Directors is expressly authorized to adopt, amend or
repeal by-laws of the Corporation.
SIXTH: Whenever a compromise or arrangement is proposed between the Corporation
and its creditors or any class of them and/or between the Corporation and its
stockholders or any class of them, any court of equitable jurisdiction within
the State of Delaware may, on the application in a summary way of the
Corporation or of any creditor or stockholder thereof, or on the application of
any receiver or receivers appointed for the Corporation under the provisions of
Section 291 of Title 8 of the Delaware Code or on the application of trustees in
dissolution or of any receiver or receivers appointed for the Corporation under
the provisions of Section 279 of Title 8 of the Delaware Code order a meeting of
the creditors or class of creditors, and/or of the stockholders or class of
stockholders of the Corporation, as the case may be, to be summoned in such
manner as the said court directs. If a majority in number representing
three-fourths in value of the creditors or class of creditors, and/or of the
stockholders or class of stockholders of the Corporation, as the case may be,
agree to any compromise or arrangement and to any reorganization of the
Corporation as a consequence of such compromise or arrangement, the said
compromise or arrangement and the said reorganization shall, if sanctioned by
the court to which the said application has been made, be binding on all the
creditors or class of creditors, and/or on all the stockholders or class of
stockholders, of the Corporation, as the case may be, and also on the
Corporation.
SEVENTH: To the fullest extent permitted by the General Corporation Law of the
State of Delaware as it now exists or may hereafter be amended, a director of
the Corporation shall not be personally liable to the Corporation or its
stockholders for monetary damages for any breach of fiduciary duty as a
director. No amendment to, or repeal of, this provision shall apply to or have
any effect on the liability or alleged liability of any director of the
Corporation for or with respect to any acts or omissions of such director
occurring prior to such amendment.
EIGHTH:
Section 8.1. Actions, Suits or Proceedings Other Than by or in the Right of the
Corporation.
(a) The Corporation shall indemnify any person who was or is a party or
is threatened to be made a party to any threatened, pending or
completed action, suit or proceeding, whether civil, criminal,
administrative or investigative (other than an action by or in the
right of the Corporation) by reason of the fact that he is or was or
has agreed to become a director or officer of the Corporation, or is
or was serving or has agreed to serve at the request of the
Corporation as a director, officer, employee or trustee of another
corporation, partnership, joint venture, trust or other enterprise
(all such persons being referred to hereafter as an "Indemnitee"),
or by reason of any action alleged to have been taken or omitted in
such capacity, against costs, charges, expenses (including
attorneys' fees), judgments, fines and amounts paid in settlement
actually and reasonably incurred by him or on his behalf in
connection with such action, suit or proceeding and any appeal
therefrom, if he acted in good faith and in a manner he reasonably
believed to be, or not opposed to, the best interests of the
Corporation, and, with respect to any criminal action or proceeding,
had no reasonable cause to believe his conduct was unlawful.
(b) The termination of any action, suit or proceeding by judgment, order,
settlement, conviction, or upon a plea of nolo contendere or its
equivalent, shall not, of itself, create a presumption that the
person did not act in good faith and in a manner which he reasonably
believed to be in, or not
Page 2 of 6
<PAGE>
opposed to, the best interests of the Corporation and, with respect
to any criminal action or proceeding, had reasonable cause to believe
that his conduct was unlawful.
(c) Notwithstanding anything to the contrary in this Article, except as
set forth in Section 8.5, the Corporation shall not indemnify an
Indemnitee seeking indemnification in connection with a proceeding
(or part thereof) initiated by the Indemnitee unless the initiation
thereof was approved by the Board of Directors of the Corporation.
Section 8.2. Actions or Suits by or in the Right of the Corporation. The
Corporation shall indemnify any person who was or is a party or is threatened to
be made a party to any threatened, pending or completed action or suit by or in
the right of the Corporation to procure a judgment in its favor by reason of the
fact that he is or was or has agreed to become a director or officer of the
Corporation or by reason of any action alleged to have been taken or omitted in
such capacity, against costs, charges and expenses (including attorneys' fees)
actually and reasonably incurred by him or on his behalf in connection with the
defense or settlement of such action or suit and any appeal therefrom, if he
acted in good faith and in a manner he reasonably believed to be in, or not
opposed to, the best interests of the Corporation, except that no
indemnification shall be made in respect of any claim, issue or matter as to
which such person shall have been adjudged to be liable to the Corporation
unless and only to the extent that the Court of Chancery of Delaware or the
court in which such action or suit was brought shall determine upon application
that, despite the adjudication of such liability, but in view of all the
circumstances of the case, such person is fairly and reasonably entitled to
indemnity for such costs, charges and expenses which the Court of Chancery or
such other court shall deem proper.
Section 8.3. Indemnification for Costs, Charges and Expenses of Successful
Party.
(a) Notwithstanding the other provisions of this Article, to the extent
that an Indemnitee has been successful on the merits, or otherwise,
including, without limitation, the dismissal of an action without
prejudice or the settlement of an action without admission of
liability, in defense of any action, suit or proceeding referred to
in Section 8.1 and Section 8.2 of this Article, or in defense of any
claim, issue or matter therein, or on appeal from any such action,
suit or proceeding, he shall be indemnified against all costs,
charges and expense (including attorneys' fees) actually and
reasonably incurred by him or on his behalf in connection therewith.
(b) Without limiting the foregoing, if any action, suit or proceeding is
disposed of, on the merits, or otherwise, (including a disposition
without prejudice), without --
(i) the disposition being adverse to the Indemnitee;
(ii) an adjudication that the Indemnitee was liable to the Corporation ;
(iii)a plea of guilty or nolo contendere by the Indemnitee;
(iv) an adjudication that the Indemnitee did not act in good faith and in
a manner he reasonably believed to be in, or not opposed to, the
best interests of the Corporation; and
(v) with respect to any criminal proceeding, without an adjudication
that the Indemnitee had reasonable cause to believe his conduct was
unlawful,
then the Indemnitee shall be considered for the purposes hereof to have
been wholly successful with respect thereto.
Section 8.4. Notification and Defense of Claim.
(a) As a condition precedent to his right to be indemnified, the
Indemnitee must give to the Corporation notice in writing as soon as
practicable of any action, suit, proceeding or investigation
involving him for which indemnity will or could be sought.
(b) With respect to an action, suit, proceeding or investigation of which
the Corporation is so notified, the Corporation will be entitled to
participate therein at its own expense and/or to assume the defense
thereof at its own expense, with legal counsel reasonably acceptable
to such Indemnitee.
Page 3 of 6
<PAGE>
(c) After notice from the Corporation to the Indemnitee of its election
so to assume such defense, the Corporation shall not be liable to the
Indemnitee for any legal or other expenses subsequently incurred by
the Indemnitee in connection with such claim, other than as provided
below in this Section 8.4. The Indemnitee shall have the right to
employ his own counsel in connection with such claim, but the fees
and expenses of such counsel incurred after notice from the
Corporation of its assumption of the defense thereof shall be at the
expense of the Indemnitee unless --
(i) the employment of counsel by the Indemnitee has been authorized by
the Corporation,
(ii) counsel to the Indemnitee shall have reasonably concluded that there
may be a conflict of interest or position on any significant issue
between the Corporation and the Indemnitee in the conduct of the
defense of such action, or
(iii)the Corporation shall not in fact have employed counsel to assume
the defense of such action,
in each of which cases the fees and expenses of counsel for the Indemnitee
shall be at the expense of the Corporation, except as otherwise expressly
provided by this Article.
(d) The Corporation shall not be entitled without the consent of the
Indemnitee to assume the defense of any claims brought by or in the
right of the Corporation or as to which counsel for the Indemnitee
shall have reasonably made the conclusion provided for in subsection
(c)(ii), above.
Section 8.5. Advances of Costs, Charges and Expenses. Subject to the provisions
of Section 8.6, below, in the event that the Corporation does not assume the
defense pursuant to Section 8.4 of this Article of any action, suit, proceeding
or investigation about which the Corporation receives notice under this Article,
any costs, charges and expenses (including attorneys' fees) actually and
reasonably incurred by an Indemnitee or on his behalf in connection with
defending a civil or criminal action, suit, proceeding or investigation or any
appeal therefrom shall be paid by the Corporation in advance of the final
disposition of such matter, provided, however, that the payment of such costs,
charges and expenses incurred by an Indemnitee in advance of the final
disposition of such matter shall be made only upon receipt of an undertaking by
or on behalf of the Indemnitee to repay all amounts so advanced in the event
that it shall ultimately be determined that such Indemnitee is not entitled to
be indemnified by the Corporation as authorized in this Article. Such
undertaking may be accepted without reference to the financial ability of such
person to make such repayment.
Section 8.6. Procedure for Indemnification.
(a) In order to obtain indemnification or advancement of expenses
pursuant to Sections 8.1, 8.2, 8.3, or 8.5, of this Article, the
Indemnitee shall submit to the Corporation a written request,
including in such request such documentation and information as is
reasonably available to the Indemnitee and is reasonably necessary to
determine whether and to what extent the Indemnitee is entitled to
indemnification or advancement of expenses.
(b) Any such indemnification or advancement of expenses shall be made
promptly, and in any event within 60 days after receipt by the
Corporation of the written request of the Indemnitee, unless with
respect to requests under Sections 8.1, 8.2, or 8.5 the Corporation
determines by clear and convincing evidence, within such 60-day
period that the Indemnitee did not meet the applicable standard of
conduct set forth in Section 8.1 or Section 8.2, as the case may be.
(c) Such determination shall be made in each instance by --
(i) a majority vote of a quorum of the directors of the Corporation
consisting of persons who are not at that time parties to the action,
suit or proceeding in question ("disinterested directors"),
(ii) if no such quorum is obtainable by a majority vote of a committee of
two or more disinterested directors;
Page 4 of 6
<PAGE>
(iii)a majority vote of a quorum of the outstanding shares of stock of all
classes entitled to vote for directors voting as a single class,
which quorum shall consist of stockholders who are not at the time
parties to the action, suit or proceeding in question;
(iv) independent legal counsel (who may be legal counsel to the
Corporation); or
(v) a court of competent jurisdiction.
Section 8.7. Remedies.
(a) The right to indemnification or advances as granted by this Article
shall be enforceable by the Indemnitee in any court of competent
jurisdiction if the Corporation denies such request, in whole or in
part, or if no disposition thereof is made within the 60-day period
referred to above in Section 8.6. Such Indemnitee's costs and
expenses incurred in connection with successfully establishing his
right to indemnification, in whole or in part, in any such proceeding
shall also be indemnified by the Corporation.
(b) Unless otherwise provided by law, the burden of proving that the
Indemnitee is not entitled to indemnification or advancement of
expenses under this Article shall be on the Corporation.
(c) Neither the failure of the Corporation to have made a determination
prior to the commencement of such action that indemnification is
proper in the circumstances because the Indemnitee has met the
applicable standard of conduct, nor an actual determination by the
Corporation pursuant to Section 8.6 that the Indemnitee has not met
such applicable standard of conduct, shall be a defense to the action
or create a presumption that the Indemnitee has not met the
applicable standard of conduct.
(d) The Indemnitee's expenses (including attorneys' fees) actually and
reasonably incurred by him or on his behalf in connection with
successfully establishing his right to indemnification, in whole or
in part, in any such proceeding shall also be indemnified by the
Corporation.
Section 8.8. Subsequent Amendment. No amendment, termination or repeal of this
Article or of relevant provisions of the Delaware General Corporation Law or any
other applicable laws shall affect or diminish in any way the rights of any
Indemnitee to indemnification under the provisions hereof with respect to any
action, suit, proceeding or investigation arising out of, or relating to any
actions, transactions or facts occurring prior to the final adoption of such
amendment, termination or repeal.
Section 8.9. Other Rights. The indemnification provided by this Article shall
not be deemed exclusive of any other rights to which an Indemnitee seeking
indemnification may be entitled under any law (common or statutory), agreement,
vote of stockholders or disinterested directors or otherwise, both as to action
in his official capacity and as to action in any other capacity while holding
office for the Corporation, and shall continue as to a person who has ceased to
be a director or officer, and shall inure to the benefit of the estate, heirs,
executors and administrators of such person. Nothing contained in this Article
shall be deemed to prohibit, and the Corporation is specifically authorized to
enter into, agreements with officers and directors providing indemnification
rights and procedures different from those set forth herein. In addition, the
Corporation, acting through its Board of Directors, may grant indemnification
rights to other employees or agents of the Corporation and such rights may be
equivalent to or greater or less than those set forth in this Article.
Section 8.10. Partial Indemnification. If an Indemnitee is entitled under any
provision of this Article to indemnification by the Corporation for some or a
portion of the costs, charges, expenses, judgments or fines actually and
reasonably incurred by him in the investigation, defense, appeal or settlement
of any proceeding but not, however, for the total amount thereof, the
Corporation shall nevertheless indemnify the Indemnitee for the portion of such
costs, charges, expenses, judgments or fines to which such Indemnitee is
entitled.
Section 8.11. Insurance. The Corporation may purchase and maintain insurance,
at its expense, to protect itself and any director, officer, employee or agent
of the Corporation or another corporation, partnership, joint venture, trust or
other enterprise against any expenses, liability or loss incurred by him
Page 5 of 6
<PAGE>
in any such capacity, or arising out of his status as such, whether or not the
Corporation would have the power to indemnify such person against such expense,
liability or loss under the Delaware General Corporation Law.
Section 8.12. Merger, Consolidation etc. If the Corporation is merged into or
consolidated with another corporation and the Corporation is not the surviving
corporation, or if substantially all of the assets or stock of the Corporation
is acquired by any other corporation, or in the event of any other similar
reorganization involving the Corporation, the Board of Directors of the
Corporation or the board of directors of any corporation assuming the
obligations of the Corporation shall assume the obligations of the Corporation
under this Article, with respect to any action, suit proceeding or investigation
arising out of or relating to any actions, transactions or facts occurring prior
to the date of such merger, consolidation, acquisition or reorganization.
Section 8.13. Savings Clause. If this Article or any portion hereof shall be
invalidated on any ground by any court of competent jurisdiction, then the
Corporation shall nevertheless indemnify each Indemnitee as to any costs,
charges, expenses (including attorneys' fees), judgments, fines and amounts paid
in settlement with respect to any action, suit, proceeding or investigation,
whether civil, criminal or administrative, including an action by or in the
right of the Corporation, to the full extent permitted by any applicable portion
of this Article that shall not have been invalidated and to the full extent
permitted by applicable law.
Section 8.14. Definitions. Terms used herein that are defined in Section 145(h)
and Section 145(i) of the Delaware General Corporation Law shall have the
respective meanings assigned to such terms in such Section 145(h) and Section
145(i).
Section 8.15. Subsequent Legislation. If the Delaware General Corporation Law is
amended after adoption of this Article to further expand the indemnification
permitted to Indemnitees, then the Corporation shall indemnify such persons to
the fullest extent permitted by the Delaware General Corporation Law, as so
amended.
NINTH. Except as otherwise provided herein, the Corporation reserves the right
to amend, alter, change or repeal any provision contained in this Restated
Certificate of Incorporation, in the manner now or hereafter prescribed by
statute and this Restated Certificate of Incorporation, and all rights conferred
upon stockholders herein are granted subject to this reservation.
In Witness Whereof, Kurzweil Applied Intelligence, Inc. has caused this
Restated Certificate of Incorporation to be signed by Thomas E. Brew, Jr., its
President, and attested by Roger M. Barzun, its Secretary, this 23rd day of
July 1996.
Kurzweil Applied Intelligence, Inc.
By: /s/ Thomas E. Brew, Jr. ATTEST: /s/ Roger M. Barzun
---------------------- --------------------
Thomas E. Brew, Jr. Roger M. Barzun
President, Chief Executive Officer & Secretary
Chairman of the Board of Directors
Page 6 of 6
EXHIBIT 10.1
KURZWEIL APPLIED INTELLIGENCE, INC.
SELLING AGENCY AGREEMENT
MAXIMUM OFFERING: $5,000,000 OF COMMON STOCK
MINIMUM OFFERING: $2,400,000 OF COMMON STOCK
Miller Johnson & Kuehn Incorporated Minneapolis, Minnesota
1660 South Highway 100 July 3, 1996
Suite 228
Minneapolis, MN 55416-1519
Gentlemen:
The undersigned, Kurzweil Applied Intelligence, Inc., (the "Company")
hereby confirms its agreement with you (the "Selling Agent") as follows:
1. DESCRIPTION OF OFFERING. The Company proposes to offer and sell
shares (the "Shares") of its common stock, $.01 par value per share (the "Common
Stock"), to private investors through you, as its agent (the "Offering"),
aggregating a minimum of $2,400,000 (the "Minimum Offering") and a maximum of
$5,000,000 (the "Maximum Offering") of gross proceeds to the Company. The Shares
will be sold at a per share price equal to the greater of (i) $2.00 or (ii)
sixty-five percent (65%) of the average of the closing prices for the Common
Stock as reported on the Nasdaq National Market for the five trading days
immediately prior to the pricing date, which shall be five business days prior
to the Closing (as hereinafter defined), but such price per share shall not
exceed $3.50. Purchases will be made pursuant to a Subscription Agreement
between the Company and each investor. The terms of the Subscription Agreement
shall be reasonably acceptable to the Company and the Selling Agent.
2. APPOINTMENT OF AGENT. On the basis of the warranties, representations
and agreements of the parties hereto, the Company hereby appoints the Selling
Agent, and the Selling Agent hereby accepts such appointment, to act as the
Company's exclusive agent in connection with the offer and sale of the Shares to
private investors, on a best efforts basis. The Selling Agent will use its best
efforts to sell the Shares, but there is no commitment by the Selling Agent to
purchase or sell all or any of the Shares. The Selling Agent may utilize the
services of sub-agents, but the use of sub-agents shall not increase the
compensation payable by the Company hereunder.
3. REPRESENTATIONS AND WARRANTIES OF THE COMPANY. The Company
represents and warrants to the Selling Agent as follows:
444948.02A
<PAGE>
(a) The Company will prepare a disclosure document or package
consisting of a description of the Offering, intended use of the
proceeds from the Offering, recent developments and risk factors
regarding the Company, and other information including the Company's
annual report on Form 10-KSB for the fiscal year ended January 31, 1996,
the Company's annual report on Form 10-K for the fiscal year ended
January 31, 1995, the Company's quarterly report on Form 10-QSB for the
fiscal quarter ended April 30, 1996, the Company's Definitive Proxy
Statement for its 1996 Annual Meeting of Stockholders, the Company's
current report on Form 8-K, dated May 9, 1996, and the Company's press
releases released since January 31, 1996 (which, together with any
supplements or amendments thereto including any documents incorporated
by reference therein is herein defined as the "Disclosure Package") with
respect to the Shares which will (i) fairly present all material
information regarding the Company; and (ii) will not include any untrue
statement of a material fact or omit to state any material fact required
to be stated therein or necessary to make the statements therein not
misleading in light of the circumstances under which they were made. The
Company will also prepare and file a Form D, if applicable, with the
Securities and Exchange Commission (the "Commission"). The Disclosure
Package and Form D will be subject to your approval, which will not be
unreasonably withheld. The Company has not taken, or omitted to take,
any action and will not take, or omit to take, any action which would
have the result of making the exemptions from registration provided by
Section 4(2) of the Securities Act of 1933, as amended (the "Securities
Act") or Regulation D thereunder unavailable for the offer and sale of
the Shares. The Company and the Selling Agent shall mutually determine
whether to issue a press release under Rule 135 of the Securities Act
and the contents of such release.
(b) As of the commencement date of the Offering and until and as
of the date of any Closing (as hereinafter defined), the Disclosure
Package will (i) fairly present all material information regarding the
Company; and (ii) not include any untrue statement of a material fact or
omit to state any material fact required to be stated therein or
necessary to make the statements therein not misleading in light of the
circumstances under which they were made; provided, that the
representations and warranties in this paragraph shall not apply to
statements or omissions made in reliance upon written information
furnished to the Company by the Selling Agent expressly for use in
preparation of the Disclosure Package.
(c) The financial statements (including all related schedules and
notes) set forth in the Disclosure Package will fairly present the
financial condition and results of operations of the Company as of the
dates and for the periods indicated; such statements will have been
prepared in accordance with generally accepted accounting principles
consistently applied throughout the periods indicated; and, in the event
the Disclosure Package shall include a report of a public accountant,
such report shall be by an independent public accountant within the
meaning of the Securities Exchange Act of 1934, as amended (the
"Exchange Act") and the rules and regulations promulgated thereunder.
(d) The Company is duly incorporated and validly existing as a
corporation in good standing under the laws of the State of Delaware,
with power and authority to own its
444948.02A
<PAGE>
properties and conduct its business, as will be described in the
Disclosure Package. The Company has no subsidiaries.
(e) The Company is duly qualified to do business as a foreign
corporation and is in good standing in all states or jurisdictions in
which the ownership or leasing of its property or the conduct of its
business requires such qualification and the failure to be so qualified
would have a material, adverse effect on the Company's business.
(f) The Company has full legal power, right and authority to
enter into this Agreement and the Agent's Warrant (as defined herein).
This Agreement and such Agent's Warrant have been duly authorized, and
this Agreement has been and as of the date of Closing such Agent's
Warrant will be executed and delivered on behalf of the Company and this
Agreement is, and such Agent's Warrant when delivered will be, the valid
and binding obligation of the Company, subject, as to enforcement, to
applicable bankruptcy, insolvency, reorganization, moratorium and other
laws affecting the rights of creditors generally, to the exercise of
judicial discretion as to the availability of equitable remedies such as
specific performance and injunction and subject, as to enforcement of
the indemnification provisions, to limitations under applicable
securities laws.
(g) Except as set forth in the Disclosure Package, the Company
has all licenses, certificates, permits and other approvals from
governmental and regulatory authorities necessary for the conduct of its
business as it is currently being carried on and as will be described in
the Disclosure Package, except those which would not have a material
adverse effect on the Company if not obtained.
(h) Except as set forth in the Disclosure Package, the Company
owns or possesses all assets, patents, patent applications, trademarks,
service marks, trade names, trademark registrations, service mark
registrations, copyrights, licenses, inventions, trade secrets and
rights necessary for the conduct of its business as it is currently
being carried on and has not received any notice of conflict with the
asserted rights of others in respect thereof. To the Company's
knowledge, and except as will be set forth in the Disclosure Package or
except as will not have a material adverse effect on the Company, no
name which the Company uses and no other aspect of the business of the
Company involves or gives rise to any infringement of any patents,
patent applications, trademarks, service marks, trade names, trademark
registrations, service mark registrations, copyrights, licenses,
inventions, trade secrets or other similar rights of others.
444948.02A
<PAGE>
(i) Since the date of the Disclosure Package and other than as
herein or therein contemplated (i) the Company has not incurred any
material liabilities or obligations, contingent or otherwise, not in the
ordinary course of business, (ii) the Company has not paid or declared
any dividend or other distribution with respect to its outstanding
capital stock, (iii) there has not been any change in the capital stock
or any material increase in the long-term debt of the Company, or any
issuance of shares of capital stock of the Company or of options,
warrants, or rights to purchase capital stock of the Company, except for
issuances of capital stock upon exercise of warrants, options or
convertible securities outstanding as of the date of the Disclosure
Package and grants of options pursuant to the Company's existing stock
option plans for which shares have been reserved for issuance, (iv) no
material loss or damage (whether or not insured) to the property of the
Company has been sustained, (v) no material legal or governmental
proceeding, domestic or foreign, affecting the Company or the
transactions contemplated by this Agreement has been instituted or, to
the best of the Company's knowledge, threatened, and (vi) there has not
been any material adverse change in the business, condition (financial
or otherwise) or properties of the Company.
(j) The Company is not in breach, default or violation of, and,
provided the Company's stockholders approve of (i) the amendment and
restatement of the Company's Certificate of Incorporation increasing the
number of shares of Common Stock the Company is authorized to issue, and
(ii) the issuance of the Shares in the Offering as required by the
Nasdaq National Market, at the Company's 1996 Annual Meeting of
Stockholders, the consummation of the transactions herein contemplated
will not result in any breach of any of the terms or conditions of, or
constitute a default or violation under, (i) the Certificate of
Incorporation or By-Laws of the Company, (ii) any material indenture,
agreement or other instrument to which the Company is now a party, or
(iii) any law or any order, rule or regulation applicable to the Company
of any court or of any federal or state regulatory body or
administrative agency having jurisdiction over the Company or its
property, except for such breaches, defaults or violations which would
not have a material adverse effect on the Company.
(k) No approval, authorization, consent or order of any
governmental or public board or body or self-regulatory organization,
other than in connection with or in compliance with the provisions of
the Securities Act, the Exchange Act and the securities laws of various
jurisdictions, is legally required for the sale of the Shares by the
Company.
(l) The Shares, when issued and delivered to the purchasers
against payment therefor in accordance with the Purchase Agreement, will
conform in all material respects to all statements made in relation
thereto contained in the Disclosure Package, and will be validly issued,
fully paid and non-assessable.
(m) Except as set forth in the Disclosure Package, there are no
pending, or to the Company's knowledge, threatened or contemplated
actions, suits or proceedings before or by any court or governmental
agency, authority or body, or any arbitrator, which are not ordinary,
routine and incidental to the business of the Company or which might
reasonably be expected
444948.02A
<PAGE>
to result in any material adverse change in the business
condition (financial or otherwise) or properties of the Company.
(n) The Disclosure Package sets forth as of the date thereof the
authorized capital stock of the Company, the number of shares which are
issued and outstanding and the number of shares reserved for issuance
upon exercise of options, warrants, rights and convertible instruments
and there has been no material change in such amounts as of the date
hereof. All outstanding shares of capital stock have been duly
authorized, validly issued, are fully paid and nonassessable and have
been issued pursuant to valid registrations under, or valid exemptions
from, the registration requirements of, the Securities Act and
applicable state blue sky laws. The capital stock of the Company shall
conform in all material respects to the description thereof contained in
the Disclosure Package.
(o) The Company has good and marketable title, free and clear of
all liens, encumbrances and equities, and of all charges or claims, to
all of the real and personal property owned by it, except liens,
encumbrances and equities, and charges or claims, which are not material
and do not materially affect the value of such property or interfere
with the conduct of its business and has valid and binding leases to all
of the real and personal property described in the Disclosure Package as
under lease to it with such exceptions as do not materially interfere
with the conduct of its business.
(p) The Company has filed all federal, state and foreign income
and franchise tax returns due prior to the date hereof and the date of
the Closing and has paid all taxes, interest and penalties shown as due
thereon; and the Company has received no notice of any material tax
deficiency which has been asserted against the Company.
(q) The Company has all requisite power and authority to issue,
sell and deliver the Shares in accordance with and upon the terms set
forth in this Agreement. The Company has duly taken all required action
for the due and proper authorization, issuance, sale and delivery of the
Shares, provided the Company's stockholders approve of (i) the amendment
and restatement of the Company's Certificate of Incorporation increasing
the number of shares of Common Stock the Company is authorized to issue,
and (ii) the issuance of the Shares in the Offering as required by the
Nasdaq National Market, at the Company's 1996 Annual Meeting of
Stockholders. No preemptive rights of security holders of the Company
exist with respect to the issuance and sale of the Shares by the
Company. No security holder of the Company possesses any registration
rights except as disclosed in the Disclosure Package.
(r) In retaining and using the proceeds from the sale of the
Shares, the Company will not be required to register as an "Investment
Company" under the Investment Company Act of 1940, as amended.
(s) Neither the Company, or to its knowledge, any of its
predecessors, any affiliated issuer nor any of the Company's directors,
officers, beneficial owners of 10% or more
444948.02A
<PAGE>
of any class of its equity securities or other affiliates nor any
promoter of the Company, is subject to any of the disabilities
enumerated in Exhibit E hereto and the representations and warranties
contained therein are true and correct.
(t) Other than as contemplated by this Agreement, the Company has
not incurred any liability for any finder's or broker's fee or agent's
commission in connection with the execution and delivery of this
Agreement or the consummation of the transactions contemplated hereby.
(u) On or prior to the Closing (as hereinafter defined) the
Company will file a notice for the listing of the Shares offered hereby
on the Nasdaq National Market.
(v) The Company is subject to the reporting requirements of the
Securities Act and the Exchange Act and (i) has timely filed all reports
and statements required to be filed thereunder in the 12 month period
prior to the date hereof except that with respect to the Company's
annual report on Form 10-KSB for its fiscal year ended January 31, 1996
the Company has timely filed a Form 12b-25 and intends to file such
10-KSB within the time period permitted by such Form 12b-25; and (ii)
each report and statement was true and complete in all material respects
when filed.
4. FURTHER AGREEMENTS OF THE COMPANY. The Company covenants and
agrees as follows:
(a) The Company will promptly deliver to the Selling Agent and
its counsel a number of copies of the Disclosure Package and each
amendment or supplement thereto as may reasonably be requested by the
Selling Agent. The Selling Agent is authorized on behalf of the Company
to use and distribute copies of the Disclosure Package in connection
with the sale of the Shares as, and to the extent, permitted by this
Agreement and Federal and applicable state securities laws.
(b) The Company will promptly notify the Selling Agent, by
telephone and in writing of (i) the issuance of any stop order
suspending the sale of securities of the Company, or of the institution
or notice of intended institution of any action or proceeding for that
purpose and (ii) any other communication directed to and received by the
Company by any public authority relating to the possible suspension of
the qualification of the offer and sale of the securities of the Company
in any state.
(c) Until the Closing (as hereinafter defined) of the Maximum
Offering or the earlier termination of this Agreement, if any event
relating to or affecting the Company, or of which the Company shall be
advised in writing by the Selling Agent, shall occur as a result of
which it is necessary, in the opinion of counsel for the Company or the
Selling Agent, to supplement or amend the Disclosure Package in order to
make the Disclosure Package not misleading in light of the circumstances
existing at the time it is delivered to a purchaser of the
444948.02A
<PAGE>
Shares, the Company will forthwith prepare an amended or
supplemented Disclosure Package (in form satisfactory to counsel for
the Selling Agent) so that the amended or supplemented Disclosure
Package will not contain any untrue statement of a material fact or
omit to state any material fact necessary in order to make the
statements therein, in the light of the circumstances existing at the
time the Disclosure Package is delivered to such purchaser, not
misleading.
(d) The Company shall pay, or cause to be paid, all expenses
incident to the performance of its obligations under this Agreement,
including all expenses incident to the delivery of the Shares; the fees
and expenses of counsel and accountants for the Company; the cost of
filing the Form D and amendments thereto; and the cost of all blue sky
filings, including legal expenses related thereto. The payment of all
such fees and expenses shall not be conditioned upon the sale of any
Shares. The Selling Agent will pay its own costs and expenses incident
to the performance of its obligations under this Agreement.
(e) The Company will apply the net proceeds from the sale of the
Shares substantially in the manner set forth in the Disclosure Package.
(f) For a period of five years from the date hereof, the Company
will furnish to the Selling Agent (i) within 100 days after the end of
each fiscal year, a copy of the Company's annual report on Form 10-KSB
or Form 10-K, including audited financial statements, together with a
report thereon of its independent public accountants, and (ii) within 55
days after the end of each of the first three quarters of each fiscal
year, the Company's quarterly report on Form 10-QSB or Form 10-Q,
including quarterly condensed financial statements of the Company.
(g) During the three-year period following the final Closing (as
defined herein), if the Company intends to engage an underwriter,
selling agent or placement agent in connection with any financing, the
Company shall notify you in writing of such intention and the proposed
terms of sale and you shall have the right of first refusal to act in
that capacity in accordance with the following provisions. The Company
shall thereafter promptly furnish you with such information concerning
the business, condition and prospects of the Company as you may
reasonably request. If, within twenty (20) days of the receipt of such
notice of intention or a statement of terms, you do not accept in
writing such offer to act as underwriter, selling agent or placement
agent with respect to such financing upon the terms proposed, the
Company shall be free to negotiate with other underwriters, selling
agents or placement agents with respect to any such financing and to
effect the same on such proposed terms. Before the Company shall accept
any proposal on terms which are materially more adverse to the Company
or are materially more favorable to the underwriter, selling agent or
placement agent than such proposed terms, your preferential right shall
be reinstated and the same procedure with respect to such notified
proposal as provided above shall be adopted. The failure by you to
exercise this right of first refusal in any particular instance shall
not affect in any way such right with respect to any subsequent
financing undertaken by the Company during the three-year period.
Notwithstanding the foregoing, the provisions of this subsection shall
not apply if the Company
444948.02A
<PAGE>
engages an underwriter, selling agent or placement agent of national
stature; as defined in Exhibit I attached hereto, provided, however,
that in such event the Company will use reasonable, good-faith efforts
to have the Selling Agent included as a co-managing underwriter,
selling agent or placement agent.
(h) If, within three (3) years from the date of the final Closing
(as defined herein), the Company shall undertake any strategic
partnership, sale of the Company or its assets, merger, acquisition of
stock or assets of another entity, or similar transaction, and shall
elect to retain an investment banker or financial advisor in connection
with such transaction, the Selling Agent shall be granted a right of
first refusal to act as the Company's investment banker or financial
advisor, in the same manner provided in subsection (g) above; provided,
however, that this subsection (h) shall not apply if the Company retains
an investment bank of national stature, as defined in Exhibit I attached
hereto, or if the Selling Agent would be subject to a conflict of
interest if retained by the Company.
(i) For a period of twelve months from the final Closing (as
defined herein), the Company shall not sell any securities, or rights to
purchase or acquire securities, except that it may issue options to
purchase shares of its common stock pursuant to its existing stock
option plans and shares of its common stock issuable upon the exercise
of options, warrants, and convertible securities outstanding on the date
hereof.
(j) The Company shall register the resale of the Shares in
accordance with the provisions of Exhibit A attached hereto. In the
event that (i) the Company shall fail to file with the Commission the
Registration Statement described in Exhibit A (the "Registration
Statement") by September 30, 1996; (ii) the Company shall fail to use
its diligent, good faith efforts to have the Registration Statement
declared effective by the Commission by November 30, 1996 and the
Registration Statement is not declared effective by November 30, 1996;
or (iii) the Registration Statement has not been declared effective by
the Commission by June 1, 1997, then, on the date of the first to occur
of (i), (ii) or (iii) above (the "Extra Warrant Date") and on each
monthly anniversary of the Extra Warrant Date thereafter until the
earlier of the effective date of the Registration Statement ("Effective
Date") or the twentieth monthly anniversary of the Extra Warrant Date,
the Company shall issue to each investor in the offering warrants
("Extra Warrants") to purchase a number of shares of common stock equal
to 5% of the number of Shares purchased by such investor in the
offering. Each Extra Warrant shall be substantially in the form of the
Agent's Warrant attached hereto as Exhibit F. Each Extra Warrant shall
entitle the holder thereof to purchase one share of common stock during
the five-year period commencing on the date of issuance. The exercise
price of the Extra Warrants shall be equal to the price per share paid
by such investor hereunder. The exercise price and number of Extra
Warrants shall be subject to adjustment in the event of a merger,
acquisition, recapitalization or stock split or reverse stock split of
shares of the Company, the issuance by the Company of a stock dividend
or any similar event. Upon issuance of the Extra Warrants, the Company
shall include the shares underlying the Extra Warrants in the
registration pursuant to the Registration Statement.
444948.02A
<PAGE>
(k) The Company shall take such actions as may be necessary to
present to its 1996 Annual Meeting of Stockholders proposals regarding
(i) the amendment and restatement of the Company's Certificate of
Incorporation increasing the number of shares of Common Stock the
Company is authorized to issue, and (ii) the issuance of the Shares in
the Offering as required by the Nasdaq National Market, and shall
deliver to the Selling Agent and Selling Agent's counsel a certificate
signed by an authorized officer of the Company that such proposals have
been validly approved by the Company's Stockholders.
(l) The Selling Agent shall be entitled to nominate one
representative to serve as a director of the Company for three years
after the date of the final Closing and the Company shall use its best
efforts to secure the election of such representative to its Board of
Directors. Such representative must be a stockholder of the Company or a
nominee of a stockholder of the Company.
5. REPRESENTATIONS, WARRANTIES AND AGREEMENTS OF SELLING AGENT.
In accepting the appointment as the Company's Selling Agent hereunder, you
hereby represent and warrant to the Company and agree with the Company that:
(a) You are a member in good standing of the National Association
of Securities Dealers, Inc.
(b) You are a licensed broker-dealer in good standing under the
Exchange Act and the rules and regulations thereunder, and the laws and
regulations of Minnesota and such other states where the Shares may be
offered or sold by you; and the Company shall not be disqualified from
relying on Rule 505 of Regulation D by reason of the application of Rule
505(b)(2)(iii) to you in the Offering.
(c) You have not offered or solicited offers to buy and will not
offer or solicit offers to buy the Shares by any form of general
solicitation or general advertising within the meaning of Rule 502(c) of
Regulation D and you will not offer any of the Shares for sale, or
solicit any offers to subscribe for or buy any of the Shares or
otherwise negotiate with any person in respect of any of the Shares,
other than on the basis of the Disclosure Package, in compliance with
Regulation D and in compliance with a Blue Sky Survey which you will
cause your counsel to prepare and provide to you and the Company. You
will require each purchaser of the Shares to execute and deliver a
Subscription Agreement in the form included with the Disclosure Package
and will promptly forward the original of such Subscription Agreement to
the Company for acceptance.
(d) In connection with the Offering, you will not represent to
any person to whom you offer Shares any material facts relating to the
Offering, the Shares, the Company, or the business of the Company,
including its future prospects, unless such facts are contained in the
444948.02A
<PAGE>
Disclosure Package or have been provided to you in writing or on
videotape by the Company specifically for such purpose.
(e) You will not offer, sell or solicit offers for the Shares to
or from any person unless, immediately before making such offer, sale or
solicitation, you reasonably believe such person (i) would be able to
represent that such person is acquiring the Shares for such person's own
account as principal for investment and not with a view to resale or
distribution, and (ii) qualifies as an "accredited investor" under Rule
501 of Regulation D. You have not taken, or omitted to take, any action
and will not take, or omit to take, any action which would have the
result of making the exemptions from registration provided by Section
4(2) of the Securities Act or Regulation D thereunder unavailable for
the offer and sale of the Shares.
(f) Upon delivery to you by the Company of the requisite number
of copies thereof, you will promptly distribute to each person to whom a
Disclosure Package was given, a copy of any amendment thereof or
supplement thereto which you have approved.
(g) The execution of this Agreement by you and your performance
of your obligations hereunder will not result in violation by you or any
other person of any state or federal law or regulation or of the rules,
regulations, or guidelines of any regulatory or other agency having
jurisdiction, including the National Association of Securities Dealers,
Inc., governing the qualification, licensing or conduct of securities
broker-dealers.
(h) You will deliver to the Company's counsel and the Company at
the Closing, a certificate, signed by an authorized officer,
substantially in the form of Exhibit G attached hereto and made a part
hereof.
(i) You acknowledge that all material non-public information, if
any, whether written or oral, furnished to you by the Company in
connection with the Offering shall be kept confidential by you, your
officers, employees, agents and affiliates; will be disclosed to such
officers, employees, agents and affiliates who shall have agreed to
maintain such confidentiality and only insofar as such officers,
employees, agents and affiliates need to know such information in
connection with performance of your services under this Agreement; and
shall be used only for purposes of this engagement hereunder. You agree
that your confidentiality obligation pursuant to the provisions of this
paragraph shall survive any termination of your engagement by the
Company.
444948.02A
<PAGE>
6. OFFERING PERIOD. Subject to applicable law, the Selling Agent shall
commence the offer and sale of the Shares to investors on or as soon as is
reasonably practicable following the date hereof and, unless otherwise
terminated hereunder shall continue to offer and sell the Shares to investors
until the earlier of (i) the date on which all of the Shares are sold, (ii) July
31, 1996 (unless extended up to 60 days by the Company and the Selling Agent at
their discretion and without notice to investors); (iii) such earlier date as
the Selling Agent and the Company mutually agree to terminate the offering; or
(iv) on such date as the Selling Agent terminates its obligations under this
Agreement as provided in Section 11 hereof. "Termination Date," as used herein,
shall refer to the date on which the offering is terminated in accordance with
the preceding sentence.
7. DELIVERY; PAYMENT AND CLOSING.
(a) A closing of the sale of Shares shall be held on or before
July 26, 1996 at a mutually agreeable time at the offices of Leonard,
Street and Deinard Professional Association, Minneapolis, Minnesota,
unless some other time and place is mutually agreed upon by the Company
and the Selling Agent. Additional closings may be held from time to time
after July 26, 1996 until the maximum number of Shares are sold (in any
such case, a "Closing.")
(b) All checks and other funds received by the Selling Agent in
subscription for the Shares shall be held by Selling Agent in accordance
with Rule 15c2-4 under the Exchange Act until the Closing of the sale of
such Shares. If the Minimum Offering has not been subscribed for on or
before July 31, 1996 (unless extended up to 60 days by the Company and
the Selling Agent), then all sums so held shall be returned to the
subscribers thereof, without interest or deduction. All subscriptions
are subject to the reasonable approval of the Company.
8. CONDITIONS TO CLOSING. The obligation of the Selling Agent
to close the Offering shall be conditioned upon the satisfaction of the
following at each Closing:
(a) The receipt by the Selling Agent of an opinion of counsel to
the Company, in the form of Exhibit B hereto.
(b) The receipt by the Selling Agent of a certificate of the
President and Chief Financial Officer of the Company, stating that the
representations and warranties contained in Section 3 hereof are true
and correct in all respects as of the date of the Closing, that the
Company has performed all of its agreements and obligations to be
performed under this Agreement and that the Disclosure Package, as of
the date of Closing, contains all material statements which are required
to be made therein, does not include any untrue statement of a material
fact or omit to state any material fact required to be stated therein or
necessary to make the statements therein not misleading in light of the
circumstances under which they were made, substantially in the form
attached hereto as Exhibit C, and acceptable to the Selling Agent.
444948.02A
<PAGE>
(c) The receipt by the Selling Agent of a certificate of the
Secretary of the Company substantially in the form attached hereto as
Exhibit D, and acceptable to the Selling Agent.
(d) The receipt by the Selling Agent of a certificate of the
Company substantially in the form attached hereto as Exhibit E, and
acceptable to the Selling Agent.
(e) The receipt by Selling Agent of the commissions and
warrants referred to in Section 9 hereof.
(f) The receipt by Selling Agent of a certificate of the
President of the Company regarding Stockholder approval of the proposals
referred to in paragraph 4(k) hereof, substantially in the form attached
as Exhibit H, and acceptable to the Selling Agent.
(g) Such other documents, opinions and certificates as the
Selling Agent may reasonably request.
The obligation of the Company to close the Offering shall be conditioned
upon the satisfaction of the following at each closing:
(a) At each Closing, the receipt by the Company of payment in
full of the proceeds from the sale of the Shares.
(b) The receipt by the Company of executed copies of all
Subscription Agreements received by the Selling Agent from subscribers
acceptable to the Selling Agent (it being understood that the Selling
Agent and the Company have the right to reject any subscriptions in
whole or in part), for review and acceptance by the Company.
(c) The receipt by the Company of a certificate of the Selling
Agent substantially in the form attached hereto as Exhibit G, and
acceptable to the Company.
9. SALES COMMISSIONS.
(a) At each Closing, and conditioned thereon, the Selling Agent
shall receive from the Company as a commission 10% of the gross proceeds
received from the sale of the Shares at such Closing. The commissions
shall be payable to or upon the order of the Selling Agent in
immediately available Minneapolis funds and may, at the option of the
Selling Agent, be netted against the gross proceeds to be delivered by
the Selling Agent to the Company.
(b) If, during the period commencing on the Termination Date, as
defined herein, and ending on the first anniversary thereof, the Company
shall sell any securities (including, but not limited to, shares of
common stock, debentures or warrants) to any purchaser who was contacted
by the Selling Agent in connection with the offer and sale of the
Shares, the Selling
444948.02A
<PAGE>
Agent shall be entitled to receive upon the sale of such securities a
commission consisting of a cash amount equal to 10% of the purchase
price paid for such securities by such purchaser. Upon any termination
of this Agreement, the Selling Agent will provide the Company with a
list of persons and entities whom the Selling Agent contacted.
(c) At each Closing, for the sum of $50.00 the Selling Agent
shall receive a warrant (the "Agent's Warrant") to purchase a number of
shares of the Company's common stock equal to 10% of the number of
Shares which have been sold in the Offering, in the form of Exhibit F
hereto with an exercise price per share equal to the per share price
paid by investors at such Closing. The Agent's Warrant shall be
exercisable for a period of ten years from the date of the Closing
subject to the exceptions contained therein.
10. INDEMNIFICATION.
(a) The Company shall indemnify and hold harmless the Selling
Agent, and each person who controls (as such term is defined by Rule 405
under the Securities Act) the Selling Agent within the meaning of the
Securities Act, against any losses, claims, damages or liabilities,
joint and several, to which the Selling Agent or such controlling
persons may become subject, under the Securities Act or otherwise,
insofar as such losses, claims, damages or liabilities (or actions in
respect thereof) arise out of or are based upon any untrue statement or
alleged untrue statement of any material fact contained in the
Disclosure Package, or any amendment or supplement thereto, or any
omission or alleged omission to state therein a material fact required
to be stated therein or necessary to make the statements therein not
misleading, and will reimburse the Selling Agent and each such
controlling person for any legal or other expenses reasonably incurred
by such Selling Agent or such controlling person (including in
settlement of any litigation, if such settlement is effected with the
written consent of the Company) in connection with investigating or
defending any such loss, claim, damage, liability or action; provided,
however, that the Company will not be liable in any such case to the
extent that such loss, claim, damage or liability arises out of or is
based upon any untrue statement or alleged untrue statement or omission
or alleged omission made in reliance upon and in conformity with written
information furnished to the Company by or on behalf of the Selling
Agent specifically for use in the preparation of the Disclosure Package
or any additions or supplements thereto. This indemnity agreement will
be in addition to any liability which the Company may otherwise have.
444948.02A
<PAGE>
(b) The Selling Agent will indemnify and hold harmless the
Company, each person who controls (as such term is defined under Rule
405 under the Securities Act) the Company within the meaning of the
Securities Act, each of its directors, and each of its officers, against
any losses, claims, damages or liabilities, joint and several, to which
the Company, any such controlling person, director or officer may become
subject, under the Securities Act or otherwise, insofar as such losses,
claims, damages or liabilities (or actions in respect thereof) arise out
of or are based upon any untrue statement or alleged untrue statement of
any material fact contained in the Disclosure Package, or any amendment
or supplement thereto, or arise out of or are based upon the omission or
the alleged omission to state therein a material fact required to be
stated therein or necessary to make the statements therein not
misleading, in each case to the extent, but only to the extent, that
such untrue statement or alleged untrue statement or omission or alleged
omission is made in the Disclosure Package or any additions or
supplements thereto, or such amendment or such supplement, in reliance
upon and in conformity with written information furnished to the Company
by the Selling Agent specifically for use in the preparation thereof;
and will reimburse the Company, any such controlling person, director or
officer for any legal or other expenses reasonably incurred by them
(including in settlement of any litigation, if such settlement is
effected with the written consent of the Selling Agent) in connection
with investigating or defending any such loss, claim, damage, liability
or action. This indemnity agreement will be in addition to any liability
which the Selling Agent may otherwise have.
(c) Promptly after receipt by an indemnified party under this
Section of notice of the commencement of any action by a third party,
such indemnified party will, if a claim in respect thereof is to be made
against any indemnifying party under this Section, notify each
indemnifying party in writing of the commencement thereof. The
indemnification provided for in this Section 10 shall not be available
to any party who fails to so notify each indemnifying party to the
extent that the indemnifying party to whom notification was not given
was unaware of the action to which the notification would have related
and was prejudiced by the failure to notify; provided, however, that the
omission to so notify each indemnifying party will not relieve any
indemnifying party from any liability which it may have to any
indemnified party otherwise than under this section. In case any such
action is brought against any indemnified party, and it seeks or intends
to seek indemnity from an indemnifying party and notifies an
indemnifying party of the commencement thereof, the indemnifying party
will be entitled to participate in, and, to the extent that it may wish,
jointly with any other indemnifying party similarly notified, to assume
the defense thereof, with counsel chosen by the indemnifying party and
reasonably satisfactory to the indemnified party; provided, however, if
the defendants in any such action (including any impleaded parties)
include both the indemnified party and the indemnifying party and the
indemnified party shall have reasonably concluded that there may be a
conflict between the positions of the indemnifying party and the
indemnified party in conducting the defense of any such action or that
there may be legal defenses available to it and/or other indemnified
parties which are different from or additional to those available to the
indemnifying party, the indemnified party or parties shall have the
right to select separate counsel (but the indemnifying party shall not
be liable for the expenses of more than one such
444948.02A
<PAGE>
separate counsel), to assume such legal defenses and to otherwise
participate in the defense of such action on behalf of such indemnified
party or parties. Upon receipt of notice from the indemnifying party to
such indemnified party of its election so to assume the defense of such
action and approval by the indemnified party of counsel, the
indemnifying party will not be liable to such indemnified party under
this section for any legal or other expenses subsequently incurred by
such indemnified party in connection with the defense thereof unless
(i) the indemnified party shall have employed separate counsel in
connection with the assumption of legal defenses in accordance with the
above proviso or (ii) the indemnifying party shall not have employed
counsel reasonably satisfactory to the indemnified party to represent
the indemnified party within a reasonable time after notice of
commencement of the action, in each of which cases the fees and
expenses of counsel shall be at the expense of the indemnifying party.
In no event shall any indemnifying party be liable in respect of any
amounts paid in settlement of any action unless the indemnifying party
shall have approved the terms of such settlement.
(d) As an interim measure during the pendency of any claim,
action, investigation, inquiry or other proceeding as to which
indemnification hereunder is sought, commencing on the one hundred
eightieth day after the service of a summons and complaint on the
Selling Agent with respect to an action for which indemnification is
sought, the Company will reimburse the Selling Agent on a monthly basis
for all reasonable legal fees or other reasonable expenses incurred in
connection with investigating or defending any such claim, action,
investigation, inquiry or other proceeding, notwithstanding the absence
of a judicial determination as to the propriety and enforceability of
the Company's obligation to reimburse the Selling Agent for such
expenses and the possibility that such payments might later be held to
have been improper by a court of competent jurisdiction. To the extent
that any such interim reimbursement payment is ultimately held to have
been improper, the Selling Agent shall promptly return it to the party
or parties that made such payment, together with interest, determined on
the basis of the base rate (or other commercial lending rate for
borrowers of the highest credit standing) announced from time to time by
Norwest Bank Minnesota, N.A., ("Prime Rate"). Any such required interim
reimbursement payments which are not made to the Selling Agent within 30
days of a request for reimbursement shall bear interest at the Prime
Rate from the date of such request.
(e) In order to provide for just and equitable contribution in
circumstances in which the indemnification provided for in Sections
10(a) or 10(b) is for any reason held, by a court of competent
jurisdiction, to be unenforceable as to any party entitled to indemnity,
the Company and the Selling Agent, or any controlling person of the
foregoing, shall contribute to the aggregate losses, claims, damages and
liabilities (including any investigation, legal and other expenses
incurred in connection with, and any amount paid in settlement of, any
action, suit or proceeding or any claims asserted) to which the Company
and the Selling Agent, or any controlling person of the foregoing, may
be subject (i) in such proportion as is appropriate to reflect the
relative benefits received by the Company, on the one hand, and the
Selling Agent on the other from the offering contemplated hereby or (ii)
if the allocation provided by clause (i) above is not permitted by
applicable law, in such proportion as is appropriate to reflect not
444948.02A
<PAGE>
only the relative benefits referred to in clause (i) above but also the
relative fault of the Company, on the one hand, and of the Selling
Agent on the other in connection with the statements or omissions which
resulted in such loss, claim, damage, liability or expense, as well as
any other relevant equitable considerations. The relative benefits
received by the Company, on the one hand, and the Selling Agent on the
other shall be deemed to be in the same proportion as the total net
proceeds from the offering (before deducting expenses) received by the
Company bear to the total sales commissions received by the Selling
Agent. The relative fault of the Company, on the one hand, and of the
Selling Agent on the other shall be determined by reference to, among
other things, whether the untrue or alleged untrue statement of a
material fact or the omission or alleged omission to state a material
fact relates to information supplied by the Company or by the Selling
Agent and the parties' relative intent, knowledge, access to
information and opportunity to correct or prevent such statement or
omission. No person guilty of fraudulent misrepresentation or guilty of
misstating or misrepresenting a material fact or failing to state a
material fact shall be entitled to contribution, as to any liability
arising from such fraudulent misrepresentation or omission, from any
person who was not guilty of such fraudulent or other misrepresentation
or omission.
11. TERMINATION.
(a) Each party hereto shall have the right to terminate its
obligations under this Agreement by giving notice to the other party as
hereinafter specified at any time on or prior to the Closing if such
other party shall have failed, refused or been unable, at or prior to
the Closing, to perform any material agreement on its part to be
performed; if there shall have been a breach of any material warranty or
representation of such other party contained herein, or because any
other material conditions of the terminating party's obligations set
forth herein are not fulfilled. Any such termination shall be without
liability of any party to any other party.
(b) If the average of the closing prices for the Common Stock as
reported on the Nasdaq National Market for the five trading days
immediately prior to the pricing date, which shall be five business days
prior to the Closing (as herein defined) is $6.00 or more, the Company
may terminate this Agreement and shall pay to the Agent all of the
Agent's out-of-pocket expenses incurred with respect to this Offering,
including the fees and expenses of counsel to the Agent.
12. REPRESENTATIONS AND AGREEMENTS TO SURVIVE. The respective covenants,
agreements, representations and warranties of the Company and the Selling Agent
hereunder, as set forth in, or made pursuant to this Agreement, shall remain in
full force and effect regardless of any investigation made by or on behalf of
any such party or any of its directors or officers or any controlling person,
and shall survive delivery of and payment for the Shares for the statutory
statute of limitations time period; and the indemnification agreements contained
in Section 10 shall also survive any termination of this Agreement.
444948.02A
<PAGE>
13. NOTICES. Except as otherwise expressly provided in this Agreement or
duly noticed hereunder, all notices and other communications hereunder shall be
in writing and, if given to the Selling Agent, shall be mailed, delivered or
telegraphed and confirmed to Miller Johnson & Kuehn Incorporated, 5500 Wayzata
Boulevard, Suite 800 - 8th Floor, Minneapolis, Minnesota 55416, Attention: Paul
R. Kuehn, with a copy to its counsel, Leonard, Street and Deinard, 150 South
Fifth Street, Suite 2300, Minneapolis, Minnesota 55402, Attention: John C. Kuehn
or, if given to the Company, shall be mailed, delivered or telegraphed and
confirmed to Kurzweil Applied Intelligence, Inc., 411 Waverley Oaks Road,
Waltham, Massachusetts 02154, Attention: Thomas E. Brew, Jr., with a copy to its
counsel, Roger M. Barzun, Esq., P.O. Box 767, Concord, Massachusetts 01742-0767.
14. MISCELLANEOUS. This Agreement shall inure to the benefit of and be
binding upon the successors of the Selling Agent and of the Company. Nothing
expressed or mentioned in this Agreement is intended or shall be construed to
give any person or corporation, other than the parties hereto and their
successors, and the controlling persons and directors and officers referred to
in Section 10 hereof, any legal or equitable right, remedy or claim under or in
respect to this Agreement or any provision hereof. The term "successors" shall
not include any purchaser of the Shares merely by reason of such purchase. No
subrogee of a benefited party shall be entitled to any benefits hereunder.
If the foregoing expresses our agreement with you, kindly confirm by
signing the acceptance on the enclosed counterpart hereof and return the same to
us, whereupon this letter and your acceptance shall become and constitute a
binding agreement between the Company and the Selling Agent in accordance with
its terms.
Very truly yours,
KURZWEIL APPLIED INTELLIGENCE, INC.
By
---------------------------------
Thomas E. Brew, Jr., President
The terms set forth in the foregoing Selling Agency Agreement between
Kurzweil Applied Intelligence, Inc. and Miller Johnson & Kuehn Incorporated are
hereby accepted and confirmed.
MILLER, JOHNSON & KUEHN INCORPORATED
By
--------------------------
Paul R. Kuehn, President
444948.02A
<PAGE>
Exhibit A
REGISTRATION RIGHTS
1. Required Registration.
---------------------
As soon as practicable but in no event later than September 30, 1996,
the Company shall file a Registration Statement under the Securities Act
covering the resale of the Shares purchased by the Investors, and will
diligently proceed to use its diligent, good faith efforts to have such
Registration Statement become effective with the Securities and Exchange
Commission (the "Commission") as soon as possible thereafter and in any event no
later than November 30, 1996.
2. Registration - General Provisions.
---------------------------------
(a) Whenever the Company is required to effect the registration
of Shares under the Securities Act, the Company will:
(i) Prepare and file with the Commission a registration
statement with respect to such securities, and use its diligent,
good faith efforts to cause such registration statement to become
effective and remain effective until the earlier of the date on
which (i) all Shares have been sold by the Investors or (ii) the
Shares may be sold by the Investors without restriction pursuant
to Rule 144(k) under the Securities Act;
(ii) prepare and file with the Commission such amendments
to such registration statement and supplements to the prospectus
contained therein as may be necessary to keep such registration
statement effective for the period required by Section 2(a)(i)
above;
(iii) provide Investors' counsel with reasonable
opportunities to review and comment on, and otherwise participate
in, the preparation of such registration statement;
(iv) furnish to the Investors participating in such
registration and to the underwriters of the securities being
registered such reasonable number of copies of the registration
statement, preliminary prospectus, final prospectus and such
other documents as the Investors and underwriters may reasonably
request in order to facilitate the public offering of such
securities;
(v) use its diligent, good faith efforts to register or
qualify the securities covered by such registration statement
under such state securities or blue sky laws of such
jurisdictions as any such Investor may reasonably request, except
that the Company shall not for any purpose be required to execute
a general consent to service of process (which shall not include
a "Uniform Consent to Service of Process" or other
1
444948.02A
<PAGE>
similar consent to service of process which relates only to
actions or proceedings arising out of or in connection with the
sale of securities, or out of a violation of the laws of the
jurisdiction requesting such consent) or to qualify to do
business as a foreign corporation in any jurisdiction wherein it
is not so qualified;
(vi) notify the Investors, promptly after it shall receive
notice thereof, of the time when such registration statement has
become effective or a supplement to any prospectus forming a part
of such registration statement has been filed;
(vii) notify the Investors promptly of any request by the
Commission for the amending or supplementing of such registration
statement or prospectus or for additional information;
(viii) prepare and file with the Commission, promptly upon
the request of any Investor, any amendments or supplements to
such registration statement or prospectus which, in the opinion
of counsel for such Investor (and concurred in by counsel for the
Company), is required under the Securities Act or the rules and
regulations thereunder in connection with the distribution of the
Shares by such Investor;
(ix) prepare and promptly file with the Commission and
promptly notify the Investors of the filing of such amendment or
supplement to such registration statement or prospectus as may be
necessary to correct any statements or omissions if, at the time
when a prospectus relating to such securities is required to be
delivered under the Securities Act, any event shall have occurred
as the result of which any such prospectus or any other
prospectus as then in effect would include an untrue statement of
a material fact or omit to state any material fact necessary to
make the statements therein, in the light of the circumstances in
which they were made, not misleading;
(x) advise the Investors, and the Investors' counsel, if
any, promptly after it shall receive notice or obtain knowledge
thereof, of the issuance of any stop order by the Commission
suspending the effectiveness of such registration statement or
the initiation or threatening of any proceeding for that purpose
and promptly use its best efforts to prevent the issuance of any
stop order or to obtain its withdrawal if such stop order should
be issued;
(xi) not file any amendment or supplement to such
registration statement or prospectus to which a majority in
interest of the Investors shall have reasonably objected on the
grounds that such amendment or supplement does not comply in all
material respects with the requirements of the Securities Act or
the rules and regulations thereunder, after having been furnished
with a copy thereof at least five business days prior to the
filing thereof, unless in the opinion of counsel for the Company
the filing of such amendment or supplement is reasonably
necessary to protect the Company from any liabilities under any
applicable federal or state law and such filing will not violate
applicable law; and
2
444948.02A
<PAGE>
(xii) at the request of any such Investor, furnish on the
effective date of the registration statement and, if such
registration includes an underwritten public offering, at the
closing provided for in the underwriting agreement: (i) opinions,
dated such respective dates, of the counsel representing the
Company for the purposes of such registration, addressed to the
underwriters, if any, and to the Investor or Investors making
such request, covering such matters as such underwriters may
reasonably request; and (ii) letters, dated such respective
dates, from the independent certified public accountants of the
Company, addressed to the underwriters, if any, and to the
Investor or Investors making such request, covering such matters
as such underwriters or Investors making such request may
reasonably request.
(b) The Company shall pay all Registration Expenses (as defined
below) in connection with the inclusion of Shares in any Registration Statement,
or application to register or qualify Shares under state securities laws, filed
by the Company hereunder, other than as set forth herein. For purposes of this
Agreement, the term "Registration Expenses" means the filing fees payable to the
Commission, any state agency and the National Association of Securities Dealers,
Inc.; the fees and expenses of the Company's legal counsel and independent
certified public accountants in connection with the preparation and filing of
the Registration Statement (and all amendments and supplements thereto) with the
Commission; and all expenses relating to the printing of the Registration
Statement, prospectuses and various agreements executed in connection with the
Registration Statement. Notwithstanding the foregoing, the Investors will pay
the fees and expenses of any legal counsel the Investors may engage, as well as
the Investors' proportionate share of any custodian fees or commission or
discounts which may be payable to any underwriter.
(c) The Investors acknowledge that there may occasionally be
times when the Company must suspend the use of the prospectus forming a part of
the Registration Statement, when there exists material non-public information
relating to the Company (including, but not limited to, an acquisition, merger,
recapitalization, consolidation, reorganization or similar transaction (or
negotiations with respect thereto)) which in the reasonable opinion of the
Company's Board of Directors should not be disclosed. Accordingly, the Company
may suspend resales pursuant to such Registration Statement for a period not to
exceed ninety (90) days in any twenty-four (24) month period if the Company has
been advised by counsel and the Board of Directors reasonably concurs that the
information the Board reasonably believes should not be disclosed is material
and therefore the prospectus forming a part of the Registration Statement is not
current. Each Investor agrees that it shall not sell any Shares pursuant to said
prospectus during the period commencing at the time at which the Company gives
the Investor notice of the suspension of the use of such prospectus and ending
at the time the Company gives the Investor notice that the Investor may
thereafter effect sales pursuant to such prospectus. The Investors shall comply
with the applicable provisions of the Securities Act and of such other
securities or blue sky laws as may be applicable in connection with the use of
such prospectus forming a part of the Registration Statement.
(d) The Company hereby indemnifies the holder of the Shares, its
officers and directors, and any person who controls such holder within the
meaning of Section 15 of the Securities Act of 1933, against all losses, claims,
damages and liabilities caused by any untrue statement of a
3
444948.02A
<PAGE>
material fact contained in any registration statement, prospectus, notification
or offering circular (and as amended or supplemented if the Company shall have
furnished any amendments or supplements thereto) or any preliminary prospectus
or caused by any omission to state therein a material fact required to be stated
therein or necessary to make the statements therein not misleading in light of
the circumstances under which they were made except insofar as such losses,
claims, damages or liabilities are caused by any untrue statement or omission
contained in information furnished in writing to the Company by such holder
expressly for use therein, and each such holder severally agrees that it will
indemnify and hold harmless the Company and each of its officers who signs such
registration statement and each of its directors and each person, if any, who
controls the Company within the meaning of Section 15 of the Securities Act of
1933 with respect to losses, claims, damages or liabilities which are caused by
any material untrue statement or omission contained in information furnished in
writing to the Company by such holder expressly for use therein.
4
444948.02A
<PAGE>
Exhibit B
FORM OF OPINION OF ROGER BARZUN
Miller, Johnson & Kuehn Incorporated
5500 Wayzata Boulevard - Suite 800
Minneapolis, MN 55416
Dear Sir/Madam:
I have acted as counsel to Kurzweil Applied Intelligence, Inc. (the
"Company"), a Delaware corporation, in connection with the execution, delivery
and performance of the Selling Agency Agreement dated as of June ____, 1996 (the
"Agency Agreement") between Miller, Johnson & Kuehn Incorporated and the
Company, in connection with the sale of a minimum of $2,400,000 and a maximum of
$4,400,000 of shares of the Company's common stock, $0.01 per share (the
"Shares").
This opinion is being furnished pursuant to Section 7(a) of the Agency
Agreement.
I have examined executed copies of the Agency Agreement; I have examined
the Company's Amended and Restated Certificate of Incorporation, as amended (the
"Charter") and its by-laws in effect on the date hereof; and I have investigated
such matters of law, made such inquiry of the officers and directors of the
Company and reviewed such other documents as I have considered advisable and
appropriate to enable me to render this opinion. I have also reviewed the
contents of the Disclosure Package (as defined in the Agency Agreement).
Based on the foregoing and in reliance thereon, and subject to the
qualifications and exceptions set forth in this letter, I am of the opinion
that:
(1) The Company has been duly incorporated and is validly existing in
good standing under the laws of the State of Delaware; has the
requisite corporate power to own, lease and operate its
properties and conduct its business as described in the
Disclosure Package; and is duly qualified to do business as a
foreign corporation in good standing in all jurisdictions where
the ownership or leasing of its properties or the conduct of its
business requires such qualification and in which the failure to
be qualified or in good standing would have a material adverse
effect on its business;
(2) The Company has the corporate power to enter into the Selling
Agency Agreement, and the Selling Agency Agreement has been duly
and validly authorized, executed and delivered by or on behalf of
the Company and is the valid and binding obligation of the
Company, enforceable in accordance with its terms.
1
444948.02A
<PAGE>
(3) The number of shares authorized and the number of outstanding
shares of capital stock of the Company set forth in the
Disclosure Package under the caption "Description of Shares" are
correct as of the date of the Disclosure Package and as of the
date hereof.
(4) All outstanding capital stock of the Company has been duly
authorized and validly issued, and is fully paid, and
nonassessable.
(5) To my knowledge, no preemptive rights, contractual or otherwise,
of securities holders of the Company exist with respect to the
issuance or sale of the Shares by the Company pursuant to this
Agreement.
(6) The Shares conform as to matters of law in all material respects
to the description concerning them made in the Disclosure
Package.
(7) The Shares have been duly authorized and, upon delivery to the
investors against payment therefor, will be validly issued, fully
paid and nonassessable. The Agent's Warrants have been duly
authorized and are the valid and binding obligation of the
Company, enforceable in accordance with their terms, and a
sufficient number of shares of the Company's common stock has
been reserved for the issuance upon exercise of the Agent's
Warrants and the shares of common stock to be issued upon
exercise of the Agent's Warrants, upon delivery on exercise and
payment therefor, will be validly issued, fully paid and
nonassessable.
(8) To my knowledge, the execution, delivery, and performance of the
Agreement will not violate or conflict with the charter or bylaws
of the Company, nor will the execution, delivery and performance
of the Agreement be in material contravention of any of the
provisions of any note, indenture, mortgage, deed of trust, joint
venture agreement, agreement or other instrument known to such
counsel to which the Company is a party or by which it is bound
and which is material to the business of the Company as a whole,
or of any material law, rule or regulation of the United States
or the Commonwealth of Massachusetts or any order, writ,
injunction or decree of any government, governmental agency, or
court having jurisdiction over the Company or any of its
properties (except that I express no opinion as to federal or
state securities laws).
(9) To the best of my knowledge, (A) there are no material statutes,
agreements, contracts, leases, or other documents or material
legal or governmental proceedings of a character required by the
Act and the Rules and Regulations to be described or referred to
in the Disclosure Package which are not so described and (B) all
descriptions of legal or governmental proceedings and of
agreements, contracts and leases contained in the Disclosure
Package constitute fair and accurate summaries of such
proceedings, agreements, contracts and leases and fairly present
the information called for with respect to the same.
2
444948.02A
<PAGE>
(10) No authorization, approval or consent of any governmental
authority or agency is necessary in connection with any issuance
and sale of the Shares, as contemplated under the Agreement,
except such as may be required under the Act or under state or
other securities laws in connection with any purchase and
distribution of such securities by the Selling Agent.
(11) Assuming the accuracy of the representations and warranties of
the purchaser in the Subscription Agreements, the offer and sale
of the Shares are exempt from registration under the Securities
Act of 1933.
(12) To the best of my knowledge, the Company is not in default of its
charter or bylaws or of any material agreements to which the
Company is a party.
(13) Although I am not opining as to, and cannot guarantee the
accuracy and completeness of the statements contained in the
Disclosure Package, in the course of my representation of the
Company nothing has come to my attention which causes me to
believe that the Disclosure Package (except as to the financial
statements and supporting financial data included or incorporated
therein, as to which such counsel need express no opinion)
contains an untrue statement of a material fact or omits to state
a material fact required to be stated therein or necessary to
make the statements therein, in light of the circumstances in
which they were made, not misleading; provided, however, that
such statement does not require any statement concerning
statements in, or omissions from, the Disclosure Package which
are based upon and conform to written information furnished to
the Company by the Selling Agent.
In rendering this opinion, I have assumed, with your consent, the
following:
(a) the genuineness of all signatures, the legal capacity of natural
persons, the authenticity of all documents submitted to me as
originals, the conformity to original documents of all documents
subjected to me as certified or photocopies thereof, the
authenticity of the originals of such copies and the execution
and delivery of the Agreement and related documents by all
parties (other than the Company); and
(b) that each document constitutes the valid and binding obligation
of each party thereto (other than Company) enforceable against
such party in accordance with its terms.
3
444948.02A
<PAGE>
The opinions expressed herein are qualified as follows:
(a) The Agency Agreement may be limited by, and be subject to,
general principles of equity, including, but not limited to, the
remedy of specific performance or injunctive relief, which may
not be available, as both are subject to the discretion of the
court before which any proceeding therefor may be brought, and
principles of materiality, reasonableness, good faith and fair
dealing (regardless of whether such enforceability is considered
in a proceeding in equity or law); by applicable bankruptcy,
insolvency, reorganization, moratorium or other laws from time to
time in effect that affect the rights of creditors, secured
parties, debtors and equity holders generally (including, but not
limited to, state or federal laws relating to fraudulent
transfers); and by federal or state securities laws as they
relate to the indemnification of persons for violations thereof.
(b) No opinion is given as to any provision of the Agency Agreement
that purports to:
(i) require the payment or reimbursement of any fee, cost,
expense or other item that is unreasonable in nature or
amount; or
(ii) release, exculpate or exempt a party from, or require
indemnification of a party for, liability for its own
action or inaction or provide an indemnity or hold
harmless to the extent such indemnity or hold harmless
relates to any activity that is determined to be contrary
to public policy.
For purposes of this opinion, I am expressing no opinion as to any laws
other than the laws of The Commonwealth of Massachusetts and the laws of the
United States of America.
I express no opinion as to the laws of any other jurisdiction.
This opinion is provided to you as a legal opinion only and not as a
guaranty or warranty of the matters discussed herein.
Without my prior written consent, this opinion may not be relied upon by
any person, firm or entity other than those to whom it is addressed. This
opinion is expressed on the date set forth above, and I do not undertake to
provide any opinions as to any matters, or to advise any person, firm or entity
with respect to any events or changes of conditions occurring subsequent to the
date hereof.
Very truly yours,
4
444948.02A
<PAGE>
Exhibit C
OFFICERS' CERTIFICATE
CERTIFICATE
OF
CHIEF EXECUTIVE OFFICER
AND CHIEF FINANCIAL OFFICER
Pursuant to Section 8(b) of the Selling Agency Agreement, dated
_____________, 1996, (the "Agency Agreement") between Kurzweil Applied
Intelligence, Inc. (the "Company") and Miller, Johnson & Kuehn, Incorporated,
the undersigned, being the duly elected Chief Executive Officer and Chief
Financial Officer, respectively, of the Company, hereby certify that:
1. Each of the representations and the warranties of the Company set
forth in Section 3 of the Agency Agreement are true and correct
on this date as if made by the Company on this date.
2. The Company has performed all of its agreements and
obligations to be performed on or prior to the Closing under the
Agency Agreement.
3. The Disclosure Package of the Company, dated ____________, 1996,
does not contain any untrue statement of a material fact or omit
to state a material fact required to be stated therein or
necessary to make the statements therein, in light of the
circumstances under which they were made, not misleading.
Dated: ____________, 1996
------------------------------------
Thomas E. Brew, Jr.
Chief Executive Officer
------------------------------------
Thomas B. Doherty
Chief Financial Officer
1
444948.02A
<PAGE>
Exhibit D
SECRETARY'S CERTIFICATE
I, Roger M. Barzun, the duly elected and acting Secretary of Kurzweil
Applied Intelligence, Inc., a Delaware corporation (the "Company"), do hereby
certify as follows:
1. Attached hereto as Exhibit A is a true, complete and correct copy of
the Amended and Restated Certificate of Incorporation of the Company, as
amended. There have been no amendments to such Amended and Restated Certificate
of Incorporation of the Company and no amendments have been authorized or
contemplated as of the date hereof.
2. Attached hereto as Exhibit B is a true, correct and complete
copy of the Bylaws of the Company.
3. Attached hereto as Exhibit C is a true, correct and complete copy of
resolutions duly adopted by unanimous written action of the Board of Directors
of the Company, effective _______________, 1996, which resolutions have not been
amended or repealed and are in full force and effect on the date hereof.
4. The following persons are the duly qualified and acting officers of
the Company duly elected or appointed to the offices set forth opposite their
respective names, and the signatures set forth opposite their names are their
true and genuine signatures:
Name Office Signature
Thomas E. Brew, Jr. President and Chief
Executive Officer _________________________
Thomas B. Doherty Treasurer and Chief
Financial Officer _________________________
Roger M. Barzun Secretary _________________________
1
444948.02A
<PAGE>
IN WITNESS WHEREOF, I have executed this Certificate the day of May,
1996.
----------------------------
Roger M. Barzun, Secretary
I, Thomas E. Brew, Jr., do hereby certify that I am the duly elected,
qualified and acting President and Chief Executive Officer of the Company, and
do further certify that Roger M. Barzun, is the duly elected, qualified and
acting Secretary of the Company and that the foregoing signature is his true and
genuine signature.
Dated: May __, 1996 ____________________________
Thomas E. Brew, Jr.
2
444948.02A
<PAGE>
Exhibit E
ISSUER BAD BOY CERTIFICATE
1. Neither the Issuer, any of its predecessors nor any affiliated
issuer:
(a) has filed a registration statement which is the subject of
any pending proceeding or examination under Section 8 of the Securities Act of
1933 (the "1933 Act") or is the subject of any refusal order or stop order
thereunder within the past five years;
(b) is subject to any pending proceeding under Rule 258
promulgated under the 1933 Act or any similar rule adopted under Section 3(b) of
the 1933 Act, or to an order entered thereunder within the past five years;
(c) has been convicted within the past five years of any felony
or misdemeanor in connection with the purchase or sale of any security or
involving the making of any false filing with the United States Securities and
Exchange Commission (the "SEC");
(d) is subject to any order, judgment, or decree of any court of
competent jurisdiction temporarily or preliminary restraining or enjoining, or
is subject to any order, judgment, or decree of any court of competent
jurisdiction, entered within the past five years, permanently restraining or
enjoining, such person from engaging in or continuing any conduct or practice in
connection with the purchase or sale of any security or involving the making of
any false filing with the SEC; or
(e) is subject to a United States Postal Service false
representation order entered under Section 3005 of Title 39, United States Code,
within the past five years; or is subject to a temporary restraining order or
preliminary injunction entered under Section 3007 of Title 39, United States
Code, with respect to conduct alleged to have violated Section 3005 of Title 39,
United States Code.
2. None of the Issuer's directors, officers, general partners, or
beneficial owners of 10% or more of any class of its equity securities
("Beneficial Owner" means a person having the power to vote or direct the vote
and/or the power to dispose or direct the disposition of such securities), nor
any of its promoters presently connected with it in any capacity:
(a) has been convicted within the past ten years of any felony or
misdemeanor in connection with the purchase or sale of any security, involving
the making of a false filing with the SEC, or arising out of the conduct of the
business of an underwriter, broker, dealer, municipal securities dealer, or
investment advisor;
(b) is subject to any order, judgment, or decree of any court of
competent jurisdiction temporarily or preliminarily enjoining or restraining, or
is subject to any order, judgment, or decree of any court of competent
jurisdiction, entered within the past five years, permanently enjoining or
restraining such person from engaging in or continuing any conduct or practice
in connection with
1
444948.02A
<PAGE>
the purchase or sale of any security or involving the making of a false filing
with the SEC, or arising out of the conduct of the business of an underwriter,
broker, dealer, municipal securities dealer, or investment advisor;
(c) is subject to an order of the SEC entered pursuant to Section
15(b), Section 15(B)(a) or 15(B)(c) of the Securities Exchange Act of 1934 (the
"1934 Act"); or is subject to an order of the SEC entered pursuant to Section
203(e) or (f) of the Investment Advisors Act of 1940;
(d) is suspended or expelled from membership in, or suspended or
barred from association with a member of, an exchange registered as a national
securities exchange pursuant to Section 6 of the 1934 Act, an association
registered as a national securities association under Section 15A of the 1934
Act, or a Canadian securities exchange or association for any act or omission to
act constituting conduct inconsistent with just and equitable principles of
trade; or
(e) is subject to a United States Postal Service false
representation order entered under Section 3005 of Title 39, United States Code,
within the past five years; or is subject to a restraining order or preliminary
injunction entered under Section 3005 of Title 39, United States Code.
3. Neither the Issuer, any of its predecessors or any affiliated issuer
nor any of the Issuer's affiliates, directors, officers, general partners,
Beneficial Owners of 10% or more of any class of the Issuer's equity securities
or promoters presently connected with the Issuer in any capacity:
(a) has filed a registration statement which (i) is the subject
of a currently effective stop order or refusal order entered pursuant to any
state's law within the past five years, (ii) is the subject of an effective
order entered against the Issuer, its officers, directors, general partners,
controlling persons or affiliates, pursuant to any state's law within the past
five years denying effectiveness to or suspending or revoking the effectiveness
of the registration statement or (iii) is the subject of any pending proceeding
or examination under the securities laws of any jurisdiction;
(b) has been convicted within the past ten years of any felony or
misdemeanor in connection with the offer, purchase or sale of any security,
franchise or commodity or involving the making of any false filing relating to
any security or offering or any felony or misdemeanor involving fraud, deceit or
intentional wrongdoing, including but not limited to forgery, embezzlement,
obtaining money under false pretenses, larceny, conspiracy to defraud,
racketeering or a transaction in securities, or of which fraud is an essential
element;
(c) is subject to any state's administrative or enforcement order
or judgment procured or entered by the state's securities administrator within
the past five years or is subject to any state's administrative or enforcement
order or judgment in which fraud, deceit or intentional wrongdoing, including
but not limited to making untrue statements of material facts or omitting to
state material facts, was found or upon which such order or judgment was based
and the order or judgment was entered within the past five years;
(d) is subject to (i) any state's administrative or enforcement
order or judgment which (A) prohibits, denies or revokes the use of any
exemption from registration in connection with
2
444948.02A
<PAGE>
the offer, purchase or sale of securities or (B) prohibits the transaction of
business by such party as a securities broker-dealer or securities agent or (ii)
any pending proceeding in any jurisdiction relating to the exemption from
registration of any security or offering;
(e) is subject to any order, judgment or decree of any court of
competent jurisdiction entered within the past five years temporarily,
preliminary or permanently restraining or enjoining such party from engaging in
or continuing any conduct or practice (including making use of any exemption) in
connection with the offer, purchase or sale of any security or commodity or
involving the making of any false filing whether or not relating to any security
or offering, or arising out of the conduct of the business of an underwriter,
broker, dealer, municipal securities dealer or investment advisor;
(f) is subject to an order, judgment or decree of a court of
competent jurisdiction entered within the past five years, enjoining or
restraining such party from engaging in or continuing any conduct or practice in
connection with the sale or purchase of securities, or involving fraud, deceit
or racketeering;
(g) has been subject to any state administrative order or
judgment in connection with the purchase or sale of securities entered within
the past five years;
(h) is subject to an order of the SEC denying or revoking
registration as a broker or dealer in securities under the 1934 Act, or is
subject to an order denying or revoking membership in a national securities
association registered under the 1934 Act, or has been suspended for a period
exceeding six months or expelled from membership in a national securities
registered under the 1934 Act.
4. If subject to the requirements of Sections 13, 14, or 15(d) of the
1934 Act, the Issuer has filed all reports required by those sections during the
past 12 calendar months (or for such shorter period that the Issuer was required
to file such reports).
KURZWEIL APPLIED INTELLIGENCE, INC.
By:
------------------------------
Its:
------------------------------
3
444948.02A
<PAGE>
Exhibit F
COMMON STOCK WARRANT
To Purchase _________
Shares of Common Stock of
Kurzweil Applied Intelligence, Inc.
___________, 1996
THE SECURITIES EVIDENCED BY THIS CERTIFICATE WERE ACQUIRED FOR
INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED. SUCH SECURITIES MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED,
HYPOTHECATED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE
REGISTRATION STATEMENT UNDER SAID ACT OR AN OPINION OF COUNSEL (WHICH SHALL BE
IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY) THAT SUCH REGISTRATION IS NOT
REQUIRED.
THIS CERTIFIES THAT, in consideration for $50.00 and other valuable
consideration, Miller, Johnson & Kuehn, Incorporated ("MJK") or its registered
assigns is entitled to subscribe for and purchase from Kurzweil Applied
Intelligence, Inc. (the "Company"), a Delaware corporation, at any time after
the date hereof to and including the Expiration Date (as defined in Section 1
hereof), ________________________ (_______) fully paid and nonassessable shares
of the Company's Common Stock, $.01 par value, at a price of $_______ per share:
This Warrant is subject to the following provisions, terms and
conditions:
1. Expiration; Exercise; Transferability.
(a) This Warrant may be exercised in whole or in part, at any
time after the date hereof to and including the Expiration Date. As used herein
"Expiration Date" shall mean _______, 2006 except that in the event the Company
achieves the financial milestones mutually agreed upon by the Company and MJK
and provides to the holder hereof written notice and documentation of such
achievement on or before August 31, 2000, then Expiration Date hereunder shall
mean _________, 2001.
(b) The rights represented by this Warrant may be exercised by
the holder hereof, in whole or in part (but not as to a fractional share of
stock), by written notice of exercise in the form appended hereto delivered to
the Company on or prior to the Expiration Date, ten (10) days prior to the
intended date of exercise and by the surrender of this Warrant (properly
endorsed if required) at the principal office of the Company and upon payment to
it in full by certified or bank check or wire transfer of the purchase price for
such shares.
1
444948.02A
<PAGE>
(c) This Warrant may be transferred subject to the following
conditions: (i) during the first year after the date of this Warrant, it may not
be sold, transferred, assigned or hypothecated except to persons who are (x)
both officers and shareholders of MJK, or (y) both officers and employees of
MJK, and (ii) after such period, the Warrant shall be transferable without
restriction, but subject to the opinion of counsel as provided by paragraph 7
herein that such transfer is not in violation of federal or state securities
laws.
2. Issuance of Shares. The Company agrees that the shares purchased
hereby shall be and are deemed to be issued to the record holder hereof as of
the close of business on the date on which this Warrant shall have been
exercised by surrender of the Warrant and payment for the shares. Subject to the
provisions of the next succeeding paragraph, certificates for the shares of
stock so purchased shall be delivered to the holder hereof within a reasonable
time, not exceeding ten (10) days after the rights represented by this Warrant
shall have been so exercised, and, unless this Warrant has expired, a new
Warrant representing the number of shares, if any, with respect to which this
Warrant shall not then have been exercised shall also be delivered to the holder
hereof within such time.
Notwithstanding the foregoing, however, the Company shall not be
required to deliver any certificate for shares of stock upon exercise of this
Warrant, except in accordance with the provisions, and subject to the
limitations, of paragraph 7 hereof.
3. Covenants of Company. The Company covenants and agrees that all
shares which may be issued upon the exercise of the rights represented by this
Warrant will upon receipt of payment therefor upon issuance, be duly authorized
and issued, fully paid, nonassessable and free from all taxes, liens and charges
with respect to the issue thereof, and, without limiting the generality of the
foregoing, the Company covenants and agrees that it will from time to time take
all such action as may be required to assure that the par value per share of the
common stock is at all times equal to or less than the then effective purchase
price per share of the common stock issuable pursuant to this Warrant. The
Company further covenants and agrees that, during the period within which the
rights represented by this Warrant may be exercised, the Company will at all
times have authorized, and reserved for the purpose of issue or transfer upon
exercise of the subscription rights evidenced by this Warrant, a sufficient
number of shares of its common stock to provide for the exercise of the rights
represented by this Warrant.
4. Anti-Dilution Adjustments. The above provisions are, however,
subject to the following:
(a) In case the Company shall at any time hereafter subdivide or
combine the outstanding shares of common stock or declare a dividend payable in
common stock, the exercise price of this Warrant in effect immediately prior to
the subdivision, combination or record date for such dividend payable in common
stock shall forthwith be proportionately increased, in the case of combination,
or decreased, in the case of subdivision or dividend payable in common stock.
Upon each adjustment of the exercise price, the holder of this Warrant shall
thereafter be entitled to purchase, at the exercise price resulting from such
adjustment, the number of shares obtained by multiplying the exercise price
immediately prior to such adjustment by the number of shares purchasable
pursuant
2
444948.02A
<PAGE>
hereto immediately prior to such adjustment and dividing the product
thereof by the exercise price resulting from such adjustment.
(b) No fractional shares of common stock are to be issued upon
the exercise of this Warrant, but the Company shall pay a cash adjustment in
respect of any fraction of a share which would otherwise be issuable in an
amount equal to the same fraction of the market price per share of common stock
on the day of exercise as determined in good faith by the Company.
(c) If any capital reorganization or reclassification of the
capital stock of the Company, or consolidation or merger of the Company with
another corporation, or the sale of all or substantially all of its assets to
another corporation shall be effected in such a way that holders of common stock
shall be entitled to receive stock, securities or assets with respect to or in
exchange for common stock, then, as a condition of such reorganization,
reclassification, consolidation, merger or sale, lawful and adequate provision
shall be made whereby the holder hereof shall thereafter have the right to
purchase and receive, upon the basis and upon the terms and conditions specified
in this Warrant and in lieu of the shares of common stock of the Company
immediately theretofore purchasable and receivable upon the exercise of the
rights represented hereby, such stock, securities or assets as may be issued or
payable with respect to or in exchange for a number of outstanding shares of
such common stock equal to the number of shares of such stock immediately
theretofore purchasable and receivable upon the exercise of the rights
represented hereby had such reorganization, reclassification, consolidation,
merger or sale not taken place, and in any such case appropriate provisions
shall be made with respect to the rights and interests of the holder of this
Warrant to the end that the provisions hereof (including without limitation
provisions for adjustments of the Warrant purchase price and of the number of
shares purchasable upon the exercise of this Warrant) shall thereafter be
applicable, as nearly as may be, in relation to any shares of stock, securities
or assets thereafter deliverable upon the exercise hereof. The Company shall not
effect any such consolidation, merger or sale unless prior to the consummation
thereof the successor corporation (if other than the Company) resulting from
such consolidation or merger, or the corporation purchasing such assets, shall
assume by written instrument executed and mailed to the registered holder hereof
at the last address of such holder appearing on the books of the Company, the
obligation to deliver to such holder such shares of stock, securities or assets
as, in accordance with the foregoing provisions, such holder may be entitled to
purchase.
Notwithstanding any language to the contrary set forth in
this paragraph 4 (c), if an occurrence or event described herein shall take
place in which the shareholders of the Company receive cash for their shares of
common stock of the Company and a successor corporation or corporation
purchasing assets shall survive the transaction then, at the election of the
record holder hereof, such corporation shall be obligated to purchase this
Warrant (or the unexercised part hereof) from the record holder without
requiring the holder to exercise all or part of the Warrant. If such corporation
refuses to so purchase this Warrant then the Company shall purchase the Warrant
for cash. In either case the purchase price shall be the amount per share that
shareholders of the outstanding common stock of the Company shall receive as a
result of the transaction multiplied by the number of shares covered by the
Warrant, minus the aggregate exercise price of the Warrant. Such purchase shall
be closed within 60 days following the election of the holder to sell this
Warrant.
3
444948.02A
<PAGE>
(d) Upon any adjustment of the Warrant purchase price, then, and
in each such case, the Company shall give written notice thereof, by first class
mail, postage prepaid, addressed to the registered holder of this Warrant at the
address of such holder as shown on the books of the Company, which notice shall
state the Warrant purchase price resulting from such adjustment and the increase
or decrease, if any, in the number of shares purchasable at such price upon the
exercise of this Warrant, setting forth in reasonable detail the method of
calculation and the facts upon which such calculation is based.
(e) If any event occurs as to which in the good faith
determination of the Board of Directors of the Company the other provisions of
this paragraph 4 are not strictly applicable or if strictly applicable would not
fairly protect the purchase rights of the holder of this Warrant or of common
stock in accordance with the essential intent and principles of such provisions,
then the Board of Directors shall make an adjustment in the application of such
provisions, in accordance with such essential intent and principles, so as to
protect such purchase rights as aforesaid.
5. Common Stock. As used herein, the term "common stock" shall mean and
include the Company's presently authorized shares of common stock and shall also
include any capital stock of any class of the Company hereafter authorized which
shall not be limited to fixed sum or percentage in respect of the rights of the
holders thereof to participate in dividends or in the distribution, dissolution
or winding up of the Company; provided that the share purchasable pursuant to
this Warrant shall include shares designated as common stock of the Company on
the date of original issue of this Warrant or, in the case of any
reclassification of the outstanding shares thereof, the stock, securities or
assets provided for in Section 4 above.
6. No Voting Rights. This Warrant shall not entitle the holder hereof
to any voting rights or other rights as a stockholder of the Company.
7. Transfer of Warrant or Resale of Shares. In the event the holder of
this Warrant desires to transfer this Warrant, or any common stock issued upon
the exercise hereof, the holder shall provide the Company with a written notice
describing the manner of such transfer in the form appended hereto and an
opinion of counsel (reasonably acceptable to the Company) that the proposed
transfer may be effected without registration or qualification (under any
Federal or State law), whereupon such holder shall be entitled to transfer this
Warrant or to dispose of shares of common stock received upon the previous
exercise hereof in accordance with the notice delivered by such holder to the
Company; provided, that an appropriate legend may be endorsed on this Warrant or
the certificates for such shares respecting restrictions upon transfer thereof
necessary or advisable in the opinion of counsel satisfactory to the Company to
prevent further transfers which would be in violation of Section 5 of the
Securities Act, as amended (the "Securities Act").
If, in the opinion of either of the counsel referred to in this
paragraph 7, the proposed transfer or disposition described in the written
notice given pursuant to this paragraph 7 may not be effected without
registration or qualification of this Warrant or the shares of common stock
issued upon the exercise hereof, the Company shall promptly give written notice
thereof to the holder hereof, and such holder will limit its activities in
respect to such proposed transfer or disposition as, in the opinion of both such
counsel, are permitted by law.
4
444948.02A
<PAGE>
8. Registration Rights.
(a) If the Company proposes to claim an exemption under Section
3(b) for a public offering of any of its securities or to register under the
Securities Act (except by a claim of exemption or registration statement on Form
S-8 or Form S-4 or any form that does not permit the inclusion of shares by its
security holders) any of its securities, it will give written notice to all
registered holders of Warrants, and all registered holders of shares of common
stock acquired upon the exercise of Warrants (the "Common Shares") of its
intention to do so and, on the written request of any such registered holders
given within twenty (20) days after receipt of any such notice, the Company will
use its best efforts to cause all Common Shares which such holders shall have
requested the registration or qualification thereof, to be included in such
notification or registration statement proposed to be filed by the Company;
provided, however, that nothing herein shall prevent the Company from, at any
time, abandoning or delaying any such registration initiated by it. If any such
registration shall be underwritten in whole or in part, the Company may require
that the shares requested for inclusion pursuant to this section be included in
the underwriting on the same terms and conditions as the securities otherwise
being sold through the underwriters. In the event that, in the good faith
judgment of the managing underwriter of such public offering, the inclusion of
all of the shares originally covered by a request for registration would reduce
the number of shares to be offered by the Company or interfere with the
successful marketing of the shares of stock offered by the Company, the number
of shares otherwise to be included pursuant to this Section in the underwritten
public offering may be proportionately reduced to a number deemed satisfactory
by the managing underwriter. Those shares which are thus excluded from the
underwritten public offering shall be withheld from the market for a period, not
to exceed 90 days from the effective date of the registration statement, which
the managing underwriter reasonably determines is necessary in order to effect
the underwritten public offering. All expenses of such offering, except the fees
of special counsel to such holders and brokers' commissions or underwriting
discounts payable by such holders, shall be borne by the Company.
(b) Further, on one occasion only upon request by the holders of
Warrants and/or the holders of shares issued upon the exercise of the Warrants
who collectively (i) have the right to purchase at least 50% of the shares
subject to the Warrants, (ii) hold directly at least 50% of the shares purchased
under the Warrants, or (iii) have the right to purchase or hold directly an
aggregate of at least 50% of the shares purchasable or purchased under the
Warrants, the Company will promptly take all necessary steps, at the option of
such holders, to register or qualify the sale of the Warrants or such shares by
the holders thereof, under the Securities Act (and, upon the request of such
holders, under Rule 415 thereunder) and such state laws as such holders may
reasonably request; provided that (i) such request must be made by the
Expiration Date; and (ii) the Company may delay the filing of any registration
statement requested pursuant to this section to a date not more than ninety (90)
days following the date of such request if in the opinion of the Company's
principal investment banker at the time of such request such a delay is
necessary in order not to adversely affect financing efforts then underway at
the Company or if in the opinion of the Company such a delay is necessary or
advisable to avoid disclosure of material nonpublic information. The costs and
expenses directly related to any registration requested pursuant to this
section, including but not limited to legal fees of the Company's counsel, audit
fees, printing expense, filing fees and fees and expenses relating to
qualifications under state securities or blue sky laws incurred by the Company
shall be borne entirely by the Company;
5
444948.02A
<PAGE>
provided, however, that the persons for whose account the securities covered by
such registration are sold shall bear the expenses of underwriting commissions
applicable to their shares and fees of their legal counsel. If the holders of
Warrants and the holders of shares of common stock underlying the Warrants are
the only persons whose shares are included in the registration pursuant to this
section, such holders shall bear the expense of inclusion of audited financial
statements in the registration statement which are not dated as of the Company's
normal fiscal year or are not otherwise prepared by the Company for its own
business purposes. The Company shall keep effective and maintain any
registration, qualification, notification or approval specified in this
paragraph for such period as may be necessary for the holders of the Warrants
and such common stock to dispose thereof, and from time to time shall amend or
supplement, at the holder's expense, the prospectus or offering circular used in
connection therewith to the extent necessary in order to comply with applicable
law.
If, at the time any written request for registration is
received by the Company pursuant to this Section 8(b), the Company has
determined to proceed with the actual preparation and filing of a registration
statement under the Securities Act in connection with the proposed offer and
sale for cash of any of its securities by it or any of its security holders,
such written request shall be deemed to have been given pursuant to Section 8(a)
hereof rather than this Section 8(b), and the rights of the holders of Warrants
and or shares issued upon the exercise of the Warrants covered by such written
request shall be governed by Section 8(a) hereof.
The managing underwriter of an offering registered
pursuant to this Section 8(b), if any, shall be selected by the holders of a
majority of the Warrants and/or shares issued upon the exercise of the Warrants
for which registration has been requested and shall be reasonably acceptable to
the Company. Without the written consent of the holders of a majority of the
Warrants and/or shares issued upon the exercise of the Warrants for which
registration has been requested pursuant to this Section 8(b), neither the
Company nor any other holder of securities of the Company may include securities
in such registration if in the good faith judgment of the managing underwriter
of such public offering the inclusion of such securities would interfere with
the successful marketing of the Warrants and/or shares issued upon the exercise
of the Warrants or require the exclusion of any portion of the Warrants and/or
shares issued upon the exercise of the Warrants to be registered. Subject to the
preceding sentence, shares to be excluded from an underwritten public offering
shall be selected in the manner provided in Section 8(a) hereof.
(c) If and whenever the Company is required by the provisions of
Sections 8(a) or 8(b) hereof to effect the registration of Warrants and/or
shares issued upon the exercise of the Warrants under the Securities Act, the
Company will:
(i) Prepare and file with the Securities and Exchange
Commission (the "Commission") a registration statement with
respect to such securities, and use its diligent, good faith
efforts to cause such registration statement to become and remain
effective until the earlier of the date on which all the
securities have been sold or the date the securities may be sold
without restriction pursuant to Rule 144(k) under the Securities
Act;
6
444948.02A
<PAGE>
(ii) prepare and file with the Commission such amendments
to such registration statement and supplements to the prospectus
contained therein as may be necessary to keep such registration
statement effective for the period required by Section 8(c)(i)
above;
(iii) provide security holders' counsel with reasonable
opportunities to review and comment on, and otherwise participate
in, the preparation of such registration statement;
(iv) furnish to the security holders participating in such
registration and to the underwriters of the securities being
registered such reasonable number of copies of the registration
statement, preliminary prospectus, final prospectus and such
other documents as such security holders and underwriters may
reasonably request in order to facilitate the public offering of
such securities;
(v) use its diligent, good faith efforts to register or
qualify the securities covered by such registration statement
under such state securities or blue sky laws of such
jurisdictions as such participating holders may reasonably
request in writing within 30 days following the original filing
of such registration statement, except that the Company shall not
for any purpose be required to execute a general consent to
service of process or to qualify to do business as a foreign
corporation in any jurisdiction wherein it is not so qualified;
(vi) notify the security holders participating in such
registration, promptly after it shall receive notice thereof, of
the time when such registration statement has become effective or
a supplement to any prospectus forming a part of such
registration statement has been filed;
(vii) notify such holders promptly of any request by the
Commission for the amending or supplementing of such registration
statement or prospectus or for additional information;
(viii) prepare and file with the Commission, promptly upon
the request of any such holders, any amendments or supplements to
such registration statement or prospectus which, in the opinion
of counsel for such holders (and concurred in by counsel for the
Company), is required under the Securities Act or the rules and
regulations thereunder in connection with the distribution of the
Warrants or shares by such holder;
(ix) prepare and promptly file with the Commission and
promptly notify such holders of the filing of such amendment or
supplement to such registration statement or prospectus as may be
necessary to correct any statements or omissions if, at the time
when a prospectus relating to such securities is required to be
delivered under the Securities Act, any event shall have occurred
as the result of which any such prospectus or any other
prospectus as then in effect would include an untrue statement
7
444948.02A
<PAGE>
of a material fact or omit to state any material fact necessary
to make the statements therein, in the light of the circumstances
in which they were made, not misleading;
(x) advise such holders, promptly after it shall receive
notice or obtain knowledge thereof, of the issuance of any stop
order by the Commission suspending the effectiveness of such
registration statement or the initiation or threatening of any
proceeding for that purpose and promptly use its best efforts to
prevent the issuance of any stop order or to obtain its
withdrawal if such stop order should be issued;
(xi) not file any amendment or supplement to such
registration statement or prospectus to which a majority in
interest of such holders shall have reasonably objected on the
grounds that such amendment or supplement does not comply in all
material respects with the requirements of the Securities Act or
the rules and regulations thereunder, after having been furnished
with a copy thereof at least five business days prior to the
filing thereof, unless in the opinion of counsel for the Company
the filing of such amendment or supplement is reasonably
necessary to protect the Company from any liabilities under any
applicable federal or state law and such filing will not violate
applicable law; and
(xii) at the request of any such holder, furnish on the
effective date of the registration statement and, if such
registration includes an underwritten public offering, at the
closing provided for in the underwriting agreement: (i) opinions,
dated such respective dates, of the counsel representing the
Company for the purposes of such registration, addressed to the
underwriters, if any, and to the holder or holders making such
request, covering such matters as such underwriters and holder or
holders may reasonably request; and (ii) letters, dated such
respective dates, from the independent certified public
accountants of the Company, addressed to the underwriters, if
any, and to the holder or holders making such request, covering
such matters as such underwriters and holder or holders may
reasonably request.
(d) The Company shall pay all Registration Expenses (as defined
below) in connection with the inclusion of Shares in any Registration Statement,
or application to register or qualify Shares under state securities laws, filed
by the Company hereunder, other than as set forth herein. For purposes of this
Agreement, the term "Registration Expenses" means the filing fees payable to the
Commission, any state agency and the National Association of Securities Dealers,
Inc.; the fees and expenses of the Company's legal counsel and independent
certified public accountants in connection with the preparation and filing of
the Registration Statement (and all amendments and supplements thereto) with the
Commission; and all expenses relating to the printing of the Registration
Statement, prospectuses and various agreements executed in connection with the
Registration Statement. Notwithstanding the foregoing, the security holder will
pay the fees and expenses of any legal counsel such holders may engage, as well
as the holder's proportionate share of any custodian fees or commission or
discounts which may be payable to any underwriter.
(e) The holders of Warrants and/or the holders of shares issued
upon the exercise of the Warrants acknowledge that there may occasionally be
times when the Company must suspend
8
444948.02A
<PAGE>
the use of the prospectus forming a part of the Registration Statement, when
there exists material non-public information relating to the Company (including,
but not limited to, an acquisition, merger, recapitalization, consolidation,
reorganization or similar transaction (or negotiations with respect thereto))
which in the reasonable opinion of the Company's Board of Directors should not
be disclosed. Accordingly, the Company may suspend resales pursuant to such
Registration Statement for a period not to exceed ninety (90) days in any
twenty-four (24) month period if the Company has been advised by counsel and the
Board of Directors reasonably concurs that the information the Board reasonably
believes should not be disclosed is material and therefore the prospectus
forming a part of the Registration Statement is not current. Each such holder
agrees that it shall not sell any Shares pursuant to said prospectus during the
period commencing at the time at which the Company gives the holder notice of
the suspension of such prospectus and ending at the time the Company gives the
holder notice that the holder may thereafter effect sales pursuant to such
prospectus.
(f) The Company hereby indemnifies the holder of this Warrant and
of any common stock issued or issuable hereunder, its officers and directors,
and any person who controls such Warrant holder or such holder of common stock
within the meaning of Section 15 of the Securities Act, against all losses,
claims, damages and liabilities caused by any untrue statement of a material
fact contained in any registration statement, prospectus, notification or
offering circular (and as amended or supplemented if the Company shall have
furnished any amendments or supplements thereto) or any preliminary prospectus
or caused by any omission to state therein a material fact required to be stated
therein or necessary to make the statements therein not misleading except
insofar as such losses, claims, damages or liabilities are caused by any untrue
statement or omission contained in information furnished in writing to the
Company by such Warrant holder or such holder of common stock expressly for use
therein, and each such holder by its acceptance hereof severally agrees that it
will indemnify and hold harmless the Company and each of its officers who signs
such registration statement and each of its directors and each person, if any,
who controls the Company within the meaning of Section 15 of the Securities Act
with respect to losses, claims, damages or liabilities which are caused by any
untrue statement or omission contained in information furnished in writing to
the Company by such holder expressly for use therein.
9. Additional Right to Convert Warrant.
(a) If at any time the shares to be issued upon exercise of this
Warrant cannot be immediately sold pursuant to an effective registration under
the Securities Act, the holder of this Warrant shall have the right to require
the Company to convert this Warrant (the "Conversion Right") at any time prior
to its expiration into shares of Common Stock as provided for in this Section 9.
Upon exercise of the Conversion Right, the Company shall deliver to the holder
(without payment by the holder of any Exercise Price) that number of shares of
Common Stock equal to the quotient obtained by dividing (x) the value of the
Warrant at the time the Conversion Right is exercised (determined by subtracting
the aggregate Exercise Price for the Warrant Shares in effect immediately prior
to the exercise of the Conversion Right from the aggregate Fair Market Value for
the Warrant Shares immediately prior to the exercise of the Conversion Right) by
(y) the Fair Market Value of one share of Common Stock immediately prior to the
exercise of the Conversion Right.
9
444948.02A
<PAGE>
(b) The Conversion Right may be exercised by the holder, at any
time or from time to time, prior to its expiration, on any business day by
delivering a written notice in the form attached hereto (the "Conversion
Notice") to the Company at the offices of the Company exercising the Conversion
Right and specifying (i) the total number of shares of Common Stock the
Warrantholder will purchase pursuant to such conversion and (ii) a place and
date not less than one nor more than 20 business days from the date of the
Conversion Notice for the closing of such purchase.
(c) At any closing under Section 9(b) hereof, (i) the holder will
surrender the Warrant and (ii) the Company will deliver to the holder a
certificate or certificates for the number of shares of Common Stock issuable
upon such conversion, together with cash, in lieu of any fraction of a share,
and (iii) the Company will deliver to the holder a new warrant representing the
number of shares, if any, with respect to which the warrant shall not have been
exercised.
(d) "Fair Market Value" means, with respect to the Company's
Common Stock, as of any date:
(i) if the Common Stock is listed or admitted to unlisted
trading privileges on any national securities exchange or is not so listed or
admitted but transactions in the Common Stock are reported on the NASDAQ
National Market System, the reported closing price of the Common Stock on such
exchange or by the NASDAQ National Market System as of such date (or, if no
shares were traded on such day, as of the next preceding day on which there was
such a trade); or
(ii) if the Common Stock is not so listed or admitted to
unlisted trading privileges or reported on the NASDAQ National Market System,
and bid and asked prices therefor in the over-the-counter market are reported by
the NASDAQ system or National Quotation Bureau, Inc. (or any comparable
reporting service), the mean of the closing bid and asked prices as of such
date, as so reported by the NASDAQ System, or, if not so reported thereon, as
reported by National Quotation Bureau, Inc. (or such comparable reporting
service); or
(iii) if the Common Stock is not so listed or admitted to
unlisted trading privileges, or reported on the NASDAQ National Market System,
and such bid and asked prices are not so reported by the NASDAQ system or
National Quotation Bureau, Inc. (or any comparable reporting service), such
price as the Company's Board of Directors determines in good faith in the
exercise of its reasonable discretion.
IN WITNESS WHEREOF, Kurzweil Applied Intelligence, Inc. has caused this
Warrant to be executed by its duly authorized officers and this Warrant to be
dated as of __________, 1996.
KURZWEIL APPLIED INTELLIGENCE, INC.
By
--------------------------------
10
444948.02A
<PAGE>
EXERCISE FORM
(TO BE SIGNED ONLY UPON EXERCISE OF WARRANT)
KURZWEIL APPLIED INTELLIGENCE, INC.
The undersigned, the holder of the within warrant, hereby irrevocably
elects to exercise the purchase right represented by such warrant for, and to
purchase thereunder ______________ shares of the Common Stock, $.01 par value,
of Kurzweil Applied Intelligence, Inc. and herewith makes payment of
$________________ therefor, and requests that the certificates for such shares
be issued in the name of _____________________________________ and be delivered
to _________________________________ whose address is.
Dated:
---------------------- ----------------------------------------
(Signature must conform in all respects
to the name of holder as specified on the
face of the warrant)
(Address)
(City - State - Zip)
11
444948.02A
<PAGE>
The undersigned pursuant to the provisions set forth in the attached
Warrant (No. ___) hereby irrevocably elects to purchase _____ shares of the
Common Stock (the "Common Stock") covered by such Warrant and herewith makes
payment of $________, representing the full purchase price for such shares at
the price per share provided for in such Warrant.
The undersigned is aware that the Common Stock has not be registered
under the Securities Act of 1933, as amended (the "Act") or any state securities
or "blue sky" laws. The undersigned understands that the reliance by the Company
on exemptions under the Act is predicated in part upon the truth and accuracy of
the statements of the undersigned in this Exercise Form.
The undersigned represents and warrants that (1) it has been furnished
with all information which it deems necessary to evaluate the merits and risks
of the purchase of the Common Stock; (2) it has had the opportunity to ask
questions concerning the Common Stock and the Company and all questions posed
have been answered to its satisfaction; (3) it has been given the opportunity to
obtain any additional information it deems necessary to verify the accuracy of
any information obtained concerning the Common Stock and the Company; and (4) it
has such knowledge and experience in financial and business matters that it is
able to evaluate the merits and risks of purchasing the Common Stock and to make
an informed investment decision relating thereto.
The undersigned hereby represents and warrants that it is purchasing the
Common Stock for its own account for investment and not with a view to the sale
or distribution of all or any part of the Common Stock.
[The undersigned understands that because the Common Stock has not been
registered under the Act, it must continue to bear the economic risk of the
investment for an indefinite time and the Common Stock cannot be sold unless the
Common Stock is subsequently registered under applicable federal and state
securities laws or an exemption from such registration is available.]
The undersigned agrees that it will in no event sell or distribute or
otherwise dispose of all or any part of the Common Stock unless (1) there is an
effective registration statement under the Act and applicable state securities
laws covering any such transaction involving the Common Stock or (2) the Company
receives an opinion of its legal counsel (concurred in by legal counsel for the
Company) stating that such transaction is exempt from registration or the
Company otherwise satisfies itself that such transaction is exempt from
registration.
The undersigned understands the terms and restrictions on the right to
dispose of the Common Stock set forth in the Warrant dated _____________, 1996
which the undersigned has carefully reviewed. The undersigned consents to the
placing of a legend on its certificate for the Common Stock referring to such
restrictions and the placing of stop transfer orders on the books of the Company
and with any transfer agents against the Common Stock until the Common Stock may
be transferred in accordance with the terms of such restrictions.
The undersigned has considered the federal and state income tax
implications of the exercise of the Warrant and the purchase and subsequent sale
of the Common Stock.
12
444948.02A
<PAGE>
------------------------------
13
444948.02A
<PAGE>
ASSIGNMENT FORM
(TO BE SIGNED ONLY UPON TRANSFER OF THE WARRANT)
For value received, the undersigned hereby sells, assigns and transfers
unto those individuals listed on Exhibit A, attached hereto, the right
represented by the within warrant to purchase the number of shares opposite
their names on the attached Exhibit A of Common Stock, $.01 par value, of
Kurzweil Applied Intelligence, Inc. to which the within warrant relates, and
appoints ______________________ attorney to transfer said right on the books of
Kurzweil Applied Intelligence, Inc., with full power of substitution in the
premises.
Dated: MILLER, JOHNSON & KUEHN,
------------------ INCORPORATED
5500 Wayzata Blvd.
Suite 800 - 8th Floor
Minneapolis, MN 55416
By
---------------------------------
In the presence of:
- -------------------------------
- -------------------------------
14
444948.02A
<PAGE>
CONVERSION NOTICE
(TO BE SIGNED ONLY UPON EXERCISE OF CONVERSION RIGHT
SET FORTH IN SECTION 9 OF THE WARRANT)
TO KURZWEIL APPLIED INTELLIGENCE, INC.:
The undersigned, the holder of the within Warrant, hereby irrevocably
elects to exercise the Conversion Right set forth in Section 9 of such Warrant
and to purchase _______________ shares of the Common Stock, of Kurzweil Applied
Intelligence, Inc. The closing of this conversion shall take place at the
offices of the undersigned on ____________________. Certificates for the shares
to be delivered at the closing shall be issued in the name of ________________
whose address is
- -------------------------------------------.
Dated:
---------------------- ----------------------------------------
(Signature must conform in all respects
to the name of holder as specified on the
face of the Warrant)
(Address)
(City - State - Zip)
15
444948.02A
<PAGE>
[Certificate of MJK]
Exhibit G
SELLING AGENT'S CERTIFICATE
Pursuant to Section 5(h) of the Selling Agency Agreement, dated June
___, 1996 (the "Agency Agreement") by and among Miller, Johnson & Kuehn,
Incorporated (the "Agent") and Kurzweil Applied Intelligence, Inc., the
undersigned, Paul R. Kuehn, the President of the Agent, and being a duly
authorized officer of the Agent, hereby certifies that:
1. The Agent has performed and complied with all of the agreements and
obligations which it is required to perform and comply with by the terms of the
Agency Agreement.
2. To the best of my knowledge, after due inquiry, each of the
representations and warranties of the Agent set forth in the Agency Agreement
are true and correct as of the date of this Certificate as if made by the Agent
on the date of this Certificate.
3. Attached hereto as Exhibit A is a true and complete listing of all
persons to whom the Agent delivered the Company's Disclosure Package, dated June
___, 1996.
Dated:
------------------------
------------------------------------------
Paul R. Kuehn
President
1
444948.02A
<PAGE>
Exhibit H
PRESIDENT'S CERTIFICATE
Pursuant to Section 4(k) of the Selling Agency Agreement, dated June
____, 1996 (the "Agency Agreement") by and between Miller, Johnson & Kuehn,
Incorporated (the "Agent") and Kurzweil Applied Intelligence, Inc. (the
"Company"), the undersigned, Thomas E. Brew, Jr., the President of the Company,
and being a duly authorized officer of the Company, hereby certifies that:
1. The attached proposals were each approved by the affirmative vote of
the majority of Stockholders of the Company on July ____, 1996, at a meeting of
the Company's Stockholders duly called in accordance with Delaware law, at which
a quorum was present, and such approval constitutes a valid action of the
Company's Stockholders.
Date:
-------------------------
-----------------------------------
Thomas E. Brew, Jr.
Exhibit I
NATIONALLY RECOGNIZED INVESTMENT BANKING FIRMS
Robertson Stephens & Co.
Needham & Co.
Merrill Lynch
Goldman Sachs
Hambrecht Quist Co.
Cowen & Co.
Paine Webber
Donaldson, Lufkin & Jenrette
Montgomery Securities
Morgan Stanley & Co.
Bear, Stearns & Co.
Smith Barney
Punk, Ziegel & Knoell
Alex, Brown & Sons
Dillon Reed & Co.
Lehman Brothers Co.
Solomon Brothers, Co.
CS First Boston Inc.
Prudential Securities
J.P. Morgan Inc.
1
444948.02A
EXHIBIT 10.2
IMPORTANT: PLEASE READ CAREFULLY BEFORE SIGNING
SIGNIFICANT REPRESENTATIONS ARE
CALLED FOR HEREIN
SUBSCRIPTION AGREEMENT
AND
LETTER OF INVESTMENT INTENT
Kurzweil Applied Intelligence, Inc. Miller, Johnson & Kuehn Incorporated
411 Waverley Oaks Road 1660 South Highway 100, Suite 228
Waltham, MA 02154 Minneapolis, Minnesota 55416
Gentlemen:
The undersigned investor ("Investor") hereby tenders this subscription and
applies for the purchase of ______________ shares of common stock, $.01 par
value (the "Shares") of Kurzweil Applied Intelligence, Inc., a Delaware
corporation (the "Company"). The subscription price for each Share is
$______________. The aggregate subscription price, in the amount of
$______________, is delivered herewith. By execution below, the
undersigned acknowledges that the Company and Miller, Johnson & Kuehn
Incorporated, as selling agent ("MJK") are relying upon the accuracy and
completeness of the representations contained herein in complying with their
obligations under applicable securities laws.
1. The undersigned acknowledges and represents as follows:
(a) That the undersigned has received, carefully reviewed and is
familiar with the Company's Confidential Private Placement
Memorandum, dated July 3, 1996, and the exhibits thereto (the
"Disclosure Package");
(b) That the undersigned is in a financial position to hold the Shares
for an indefinite period of time and is able to withstand a complete
loss of its investment in the Shares;
(c) That the undersigned has substantial experience in evaluating and
investing in private placement transactions of securities in
companies similar to the Company, so that it is capable of
evaluating the merits and risks of its investment in the Company and
has the capacity to protect its own interests;
(d) That by reason of its business or financial experience, the
undersigned has the capacity to protect its own interests in
connection with this purchase;
<PAGE>
(e) That the undersigned acknowledges that the undersigned has made its
own investigation of the Company, its business, personnel and
prospects; has had an opportunity to discuss the Company's business,
management and financial affairs with directors, officers and
management of the Company; and has had the opportunity to review the
Company's operations and facilities to its satisfaction;
(f) That the undersigned has such knowledge and experience in financial
and business matters that it is capable of evaluating the merits and
risks of the prospective investment in the Shares and has the net
worth to undertake such risks;
(g) That the undersigned believes that the investment in the Shares is
suitable for it based upon its investment objectives and financial
needs, and the undersigned has adequate means for providing for its
current financial needs and contingencies and has no need for
liquidity of investment with respect to the Shares;
(h) That the undersigned recognizes that the Shares as an investment
involve a high degree of risk including, but not limited to, the
risk of economic losses from operations of the Company and the total
loss of its investment;
(i) That the undersigned realizes that (1) the purchase of the
Shares is a long- term investment, (2) the purchaser of the Shares
must bear the economic risk of investment for an indefinite period
of time because the Shares have not been registered under the
Securities Act of 1933 (the "Act") and, therefore, cannot be sold
unless they are subsequently registered under the said Act or an
exemption from such registration is available and (3) the
transferability of the Shares is restricted and (A) requires
conformity with the restrictions contained in paragraph 2 below, and
(B) will be further restricted by a legend placed on the
certificate(s) representing the Shares stating that they have not
been registered under the Act and referencing the restrictions on
transferability; and
(j) That the undersigned is not relying on any representations,
warranties or information provided by MJK.
1411512.01
<PAGE>
2. The undersigned has been advised that the Shares are not being
registered under the Act or relevant state securities laws but are being offered
and sold pursuant to exemptions from such laws and that the Company's and MJK's
reliance upon such exemptions is predicated in part on the undersigned's
representations as contained herein.
The undersigned represents and warrants that the Shares are being purchased for
its own account and for investment and without the intention of reselling or
redistributing the same, that it has made no agreement with others regarding any
of such Shares and that its financial condition is such that it is not likely
that it will be necessary to dispose of any of the Shares the foreseeable
future. The undersigned is aware that, in the view of the Securities and
Exchange Commission, a purchase of securities with an intent to resell any of
the same by reason of any foreseeable specific contingency or anticipated change
in market value, or any change in the condition of the Company, or in connection
with a contemplated liquidation or settlement of any loan obtained for the
acquisition of the securities and for which the securities were pledged as
security, would represent an intent inconsistent with the representations set
forth above. The undersigned further represents and agrees that if, contrary to
its foregoing intentions, it should later desire to dispose of or transfer any
of the Shares in any manner, it shall not do so without first obtaining (1) the
opinion of counsel reasonably acceptable to the Company that such proposed
disposition or transfer lawfully may be made without the registration of such
Securities pursuant to the Act, as then amended, and applicable state securities
laws, or (2) such registration.
3. The undersigned represents and warrants that, if an individual, he or
she is a bona fide resident of, and is domiciled in, the State of
______________, and, if an entity, that its executive offices are located in the
State of ______________, and that the Shares are being purchased by it in its
name solely for its own beneficial interest and not as nominee for, or on behalf
of, or for the beneficial interest of, or with the intention to transfer to, any
other person, trust or organization.
The undersigned agrees to furnish any additional information which the
Company deems necessary in order to verify the answers set forth below.
4. The undersigned understands that the representations contained below
are made for the purpose of qualifying it as an "accredited investor" as that
term is defined in Regulation D of the General Rules and Regulations under the
Act and for the purpose of inducing a sale of securities to it. The undersigned
hereby represents that the statement or statements initialed below are true and
correct in all respects. The undersigned understands that a false representation
may constitute a violation of law, and that any person who suffers damage as a
result of a false representation may have a claim against the undersigned for
damages.
(a) Accredited individual investors must initial one or both of the
following statements:
1411512.01
<PAGE>
_____ (1) I certify that I am an accredited
investor because I had individual income (exclusive of
any income attributable to my spouse) of more than
$200,000 in each of the most recent two years or joint
income with my spouse of more than $300,000 in each of
such years and I reasonably expect to have such an
income in excess of such amounts for the current year.
_____ (2) I certify that I am an accredited investor because I
have an individual net worth, or my spouse and I have a
combined individual net worth, in excess of $1,000,000.
For purposes of this Subscription Agreement "individual
net worth" means the excess of total assets at fair
market value, including home and personal property, over
total liabilities.
(b) Accredited partnerships, corporations or other entities must initial
one or more of the following statements:
_____ (1) The undersigned hereby certifies that all of the
beneficial equity owners of the undersigned qualify as
accredited individual investors under items 1 or 2
above. (Investors attempting to qualify under this item
must complete the Certificate of Signatory to this
Subscription Agreement and Letter of Investment Intent
and each equity owner must complete a separate copy of
this Agreement and Letter);
_____ (2) The undersigned is a bank or savings and loan
association as defined in Sections 3(a)(2) and
3(a)(5)(A), respectively, of the Act acting either in
its individual or fiduciary capacity.
_____ (3) The undersigned is an insurance company as defined in
Section 2(13) of the Act.
_____ (4) The undersigned is an investment company registered
under the Investment Company Act of 1940 or a business
development company as defined in Section 2(a)(48) of
that Act.
_____ (5) The undersigned is a Small Business Investment Company
licensed by the U.S. Small Business Administration under
Section 301(c) or (d) of the Small Business Investment
Act of 1958.
1411512.01
<PAGE>
_____ (6) The undersigned is an employee benefit plan within the
meaning of Title I of the Employee Retirement Income
Security Act of 1974 and either (check one or more, as
applicable):
_____ (a) the investment decision is made by a
plan fiduciary, as defined in Section 3(21)
of such Act, which is either a bank, savings
and loan association, insurance company, or
registered investment adviser; or
_____ (b) the employee benefit plan has total assets
in excess of $5,000,000; or
_____ (c) the plan is a self-directed plan with
investment decisions made solely by persons
who are "Accredited Investors" as defined
under the Act.
_____ (7) The undersigned is a private business development
company as defined in Section 202(a)(22) of the
Investment Advisers Act of 1940.
_____ (8) The undersigned has total assets in excess of
$5,000,000, was not formed for the specific purpose of
acquiring Shares and is one or more of the following
(check one or more, as appropriate):
_____ (a) an organization described in Section
501(c)(3) of the Internal Revenue Code; or
_____ (b) a corporation; or
_____ (c) a Massachusetts or similar business trust;
or
_____ (d) a partnership.
_____ (9) The undersigned is a trust with total assets
exceeding $5,000,000, which was not formed for the
specific purpose of acquiring Shares and whose purchase
is directed by a person who has such knowledge and
experience in financial and business matters that he or
she is capable of evaluating the merits and risks of the
investment in the Shares.
5. The undersigned, if other than an individual, makes the following
additional representation:
1411512.01
<PAGE>
(a) this Agreement has been duly authorized by all necessary action on
the part of the undersigned, has been duly executed by an authorized
officer or representative of the undersigned, and is a legal, valid
and binding obligation of the undersigned enforceable in accordance
with its terms.
6. Registration Rights. The Company hereby grants the Investor the
registration rights covering the Shares set forth in Exhibit A attached hereto.
7. Manner in Which Title is to be Held. (check one)
(a) _____ Individual Ownership
(b) _____ Community Property
(c) _____ Joint Tenant with Right of Survivorship
(both parties must sign)
(d) _____ Partnership
(e) _____ Tenants in Common
(f) _____ Corporation
(g) _____ Trust
(h) _____ Other
* * * * * * * *
1411512.01
<PAGE>
Dated: ________________, 1996
INDIVIDUAL INVESTORS ENTITY INVESTORS
---------------------------------
Name of Entity, if any
- ----------------------------
Signature (Individual)
By
------------------------------
*Signature
Its
- ---------------------------- ------------------------------
Signature Title
(all record holders should sign)
- ---------------------------- ---------------------------------
Name(s) Typed or Printed Name Typed or Printed
- ---------------------------- ---------------------------------
Address to Which Correspon- Address to Which Correspon-
dence Should be Directed dence Should be Directed
============================ =================================
City, State and Zip Code City, State and Zip Code
- ---------------------------- ---------------------------------
Tax Identification or Tax Identification or
Social Security Number Social Security Number
* If Shares are being subscribed for by any entity, the Certificate of
Signatory must also be completed.
<PAGE>
CERTIFICATE OF SIGNATORY
(To be completed if Shares are being subscribed
for by an entity)
I, ____________________________________, the _______________
__________________ of ___________________________________________ (the
"Entity"), hereby certify that I am empowered and duly authorized by the Entity
to execute and carry out the terms of the Subscription Agreement and Letter of
Investment Intent and to purchase the Shares, and certify further that the
Subscription Agreement and Letter of
Investment Intent has been duly and validly executed on behalf of the Entity and
constitutes a legal and binding obligation of the Entity.
IN WITNESS WHEREOF, I have set my hand this ____ day of ______________,
1996.
-----------------------------------
(Signature)
1411512.01
<PAGE>
ACCEPTANCE
By accepting the foregoing Subscription, the Company hereby grants the
Investors registration rights with respect to the Shares as are set forth in
Exhibit A attached hereto.
KURZWEIL APPLIED INTELLIGENCE, INC.
By
-----------------------------------
1411512.01
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> JAN-31-1997
<PERIOD-START> MAY-1-1996
<PERIOD-END> JUL-31-1996
<EXCHANGE-RATE> 1
<CASH> 3,179
<SECURITIES> 0
<RECEIVABLES> 2,124
<ALLOWANCES> 0
<INVENTORY> 473
<CURRENT-ASSETS> 6,119
<PP&E> 821
<DEPRECIATION> 0
<TOTAL-ASSETS> 10,499
<CURRENT-LIABILITIES> 4,453
<BONDS> 0
0
0
<COMMON> 91
<OTHER-SE> 4,803
<TOTAL-LIABILITY-AND-EQUITY> 10,499
<SALES> 0
<TOTAL-REVENUES> 2,197
<CGS> 860
<TOTAL-COSTS> 2,966
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 1
<INCOME-PRETAX> (738)
<INCOME-TAX> 0
<INCOME-CONTINUING> (738)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (738)
<EPS-PRIMARY> (0.09)
<EPS-DILUTED> (0.09)
</TABLE>
